<SEC-DOCUMENT>0000929638-24-003440.txt : 20241004
<SEC-HEADER>0000929638-24-003440.hdr.sgml : 20241004
<ACCEPTANCE-DATETIME>20241004164417
ACCESSION NUMBER:		0000929638-24-003440
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20241001
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
ITEM INFORMATION:		Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20241004
DATE AS OF CHANGE:		20241004

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Freshpet, Inc.
		CENTRAL INDEX KEY:			0001611647
		STANDARD INDUSTRIAL CLASSIFICATION:	GRAIN MILL PRODUCTS [2040]
		ORGANIZATION NAME:           	04 Manufacturing
		IRS NUMBER:				201884894
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36729
		FILM NUMBER:		241355400

	BUSINESS ADDRESS:	
		STREET 1:		1545 U.S. 206, 1ST FLOOR
		CITY:			BEDMINSTER
		STATE:			NJ
		ZIP:			07921
		BUSINESS PHONE:		201-520-4000

	MAIL ADDRESS:	
		STREET 1:		1545 U.S. 206, 1ST FLOOR
		CITY:			BEDMINSTER
		STATE:			NJ
		ZIP:			07921
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>a8k.htm
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:srt="http://fasb.org/srt/2024" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:currency="http://xbrl.sec.gov/currency/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:naics="http://xbrl.sec.gov/naics/2024" xmlns:sic="http://xbrl.sec.gov/sic/2024" xmlns:stpr="http://xbrl.sec.gov/stpr/2024" xmlns:exch="http://xbrl.sec.gov/exch/2024" xmlns:cef="http://xbrl.sec.gov/cef/2024" xmlns:frpt="http://freshpet.com/20241001" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: Morgan Lewis
         Document created using Broadridge PROfile 24.8.1.5246
         Copyright 1995 - 2024 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html"/>
</head>

<body style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000; background-color: #ffffff;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_8719ba46677140f8a553862cf9201145" contextRef="c20241001to20241001" format="ixt:fixed-false">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_4a22d9d8b0c64e2dbcd69ed8b81b38c4" contextRef="c20241001to20241001">0001611647</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="frpt-20241001.xsd" xlink:type="simple"/></ix:references><ix:resources><xbrli:context id="c20241001to20241001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001611647</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-01</xbrli:startDate><xbrli:endDate>2024-10-01</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>
<div style="line-height: initial;">
  <div><br/>
  </div>

  <div style="font-family: 'Times New Roman', Times, serif;">
    <div style="color: #000000;">
      <div>
        <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"/></div>

      <div style="text-align: center; font-size: 14pt; font-weight: bold;">UNITED STATES</div>

      <div style="text-align: center; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>

      <div style="text-align: center; font-size: 12pt; font-weight: bold;">Washington, D.C. 20549</div>

      <div style="padding-bottom: 6pt;"> <br/>
      </div>

      <div style="text-align: center; font-size: 18pt; font-weight: bold;">FORM <ix:nonNumeric name="dei:DocumentType" id="Fact_94b11ffce3ed466b9ba38a12c9ab0409" contextRef="c20241001to20241001">8-K</ix:nonNumeric></div>

      <div style="text-align: center; font-weight: bold; font-size: 12pt;"> <span style="font-weight: bold;"><br/>
        </span></div>

      <div><span style="font-weight: bold;"> </span></div>

      <div style="text-align: center; font-size: 10pt; font-weight: bold;">CURRENT REPORT</div>

      <div><span style="font-weight: bold;"> </span></div>

      <div style="text-align: center; font-size: 10pt; font-weight: bold;">PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</div>

      <div><span style="font-weight: bold;"> </span></div>

      <div style="font-size: 10pt;"> <span style="font-weight: bold;"><br/>
        </span> </div>

      <div><span style="font-weight: bold;"> </span></div>

      <div style="text-align: center; font-size: 10pt; font-weight: bold;">Date of Report (Date of earliest event reported):&#160; <ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_e6e52aba8de04d50857d4680e72c04b2" contextRef="c20241001to20241001" format="ixt:date-monthname-day-year-en">October 1, 2024</ix:nonNumeric></div>

      <div style="font-size: 12pt;"> <br/>
      </div>

      <div style="text-align: center; font-size: 24pt; font-weight: bold; text-transform: uppercase;"><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_a9b5e8a22142426cab4c38dce8b9c239" contextRef="c20241001to20241001">Freshpet, Inc.</ix:nonNumeric><br/>
      </div>

      <div style="font-size: 10pt; text-align: center; font-weight: bold;">(Exact name of registrant as specified in its charter) </div>

      <div><span style="font-weight: bold;"> </span></div>

      <div style="font-size: 10pt; padding-bottom: 12pt;"> <span style="font-weight: bold;"><br/>
        </span> </div>

      <div><span style="font-weight: bold;"> </span></div>

      <table cellspacing="0" cellpadding="0" style="width: 100%; text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">


  <tr>

    <td style="width: 30%; vertical-align: bottom; border-bottom: 2px solid #000000; font-size: 10pt;">
              <div style="text-align: center; font-weight: bold;"><span style="font-weight: bold;"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_d73bb40c90124970ba2c53fcc32fd5eb" contextRef="c20241001to20241001" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric><br/>
                </span> </div>
            </td>

    <td style="width: 5%; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt;">
              <div style="text-align: left; font-weight: bold;">&#160;</div>
            </td>

    <td style="width: 30%; vertical-align: bottom; border-bottom: 2px solid #000000; font-size: 10pt;">
              <div style="text-align: center; font-weight: bold;"><span style="font-weight: bold;"><ix:nonNumeric name="dei:EntityFileNumber" id="Fact_f3b4c45146404374ac91e2beff8de354" contextRef="c20241001to20241001">001-36729</ix:nonNumeric><br/>
                </span> </div>
            </td>

    <td style="width: 5%; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt;">
              <div style="text-align: left; font-weight: bold;">&#160;</div>
            </td>

    <td style="width: 30%; vertical-align: bottom; border-bottom: 2px solid #000000; font-size: 10pt;">
              <div style="text-align: center; font-weight: bold;"><span style="font-weight: bold;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_318477988b4e46b3a4882c5af0d7e8ff" contextRef="c20241001to20241001">20-1884894</ix:nonNumeric><br/>
                </span> </div>
            </td>

  </tr>

  <tr>

    <td style="width: 30%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; font-weight: bold;">(State or other jurisdiction <br/>
                of incorporation)</div>
            </td>

    <td style="width: 5%; vertical-align: bottom; font-size: 10pt;">
              <div style="text-align: left; font-weight: bold;">&#160;</div>
            </td>

    <td style="width: 30%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; font-weight: bold;">(Commission <br/>
                File Number)</div>
            </td>

    <td style="width: 5%; vertical-align: bottom; font-size: 10pt;">
              <div style="text-align: left; font-weight: bold;">&#160;</div>
            </td>

    <td style="width: 30%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; font-weight: bold;">(IRS Employer <br/>
                Identification No.)</div>
            </td>

  </tr>


</table>
      <div><span style="font-weight: bold;"> </span></div>

      <div style="font-size: 8pt;"> <span style="font-weight: bold;"><br/>
        </span> </div>

      <div><span style="font-weight: bold;"> </span></div>

      <table cellspacing="0" cellpadding="0" style="width: 100%; text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">


  <tr>

    <td style="width: 47%; vertical-align: bottom; border-bottom: 2px solid #000000; text-align: center; font-size: 10pt; font-weight: bold;">
              <div style="font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_005ee561ce004326be248d2ca1d4aeac" contextRef="c20241001to20241001">1545 US-206</ix:nonNumeric></div>
              <div style="font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_64c94359c0ac42b8b7b81a344a353cf8" contextRef="c20241001to20241001">Bedminster</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="Fact_7622f32dff2742edb5adda4c4f47802f" contextRef="c20241001to20241001" format="ixt-sec:stateprovnameen">New Jersey</ix:nonNumeric></div>
            </td>

    <td style="width: 6%; vertical-align: bottom; padding-bottom: 2px; font-size: 10pt;">
              <div style="text-align: left; font-weight: bold;">&#160;</div>
            </td>

    <td style="width: 47%; vertical-align: bottom; text-align: center; font-size: 10pt; border-bottom: 2px solid #000000; font-weight: bold">
              <div><span style="font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_0df34df1e82c42d98870256de5317e84" contextRef="c20241001to20241001">07921</ix:nonNumeric><br/>
                </span> </div>
            </td>

  </tr>

  <tr>

    <td style="width: 47%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; font-weight: bold;">(Address of principal executive offices)</div>
            </td>

    <td style="width: 6%; vertical-align: bottom; font-size: 10pt;">
              <div style="text-align: left; font-weight: bold;">&#160;</div>
            </td>

    <td style="width: 47.48%; vertical-align: top; font-size: 10pt;">
              <div style="text-align: center; font-weight: bold;">(Zip code)</div>
            </td>

  </tr>


</table>
      <div><span style="font-weight: bold;"> </span></div>

      <div style="font-size: 10pt;"> <span style="font-weight: bold;"><br/>
        </span> </div>

      <div><span style="font-weight: bold;"> </span></div>

      <div style="text-align: center; font-size: 10pt; font-weight: bold;"><span style="font-weight: bold;">Registrant's telephone number, including area code:&#160; </span><ix:nonNumeric name="dei:CityAreaCode" id="Fact_3e20be1178ce4249a53e409e9fca219c" contextRef="c20241001to20241001">201</ix:nonNumeric> <ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_98689e1658eb4392a424a125add0bb88" contextRef="c20241001to20241001">520-4000</ix:nonNumeric></div>

      <div><span style="font-weight: bold;"> </span></div>

      <div style="font-size: 10pt;"><span style="font-weight: bold;"> </span><br/>
      </div>

      <div style="text-align: center; font-size: 10pt; font-weight: bold;">Not Applicable</div>

      <div><span style="font-weight: bold;"> </span></div>

      <div style="text-align: center; font-size: 10pt; font-weight: bold;">(Former Name or Former Address, if Changed Since Last Report)</div>

      <div><span style="font-weight: bold;"> </span></div>

      <div style="font-size: 10pt; text-align: center;"><span style="font-weight: bold;"> </span>___________________<br/>
      </div>

      <div style="font-size: 10pt;">
<div><span style="font-weight: bold;"> </span></div>

        <div style="text-align: left; margin-top: 6pt; margin-bottom: 6pt; font-size: 10pt;"> Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following
          provisions: </div>

        <div style="text-align: left; margin-bottom: 7.1pt; font-size: 10pt;"><ix:nonNumeric name="dei:WrittenCommunications" id="Fact_c48f18e9c5ff4fef980264a31beeaab1" contextRef="c20241001to20241001" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric> Written communications pursuant to Rule 425 under the Securities
          Act (17 CFR 230.425)</div>

        <div style="text-align: left; margin-bottom: 6.95pt; font-size: 10pt;"><ix:nonNumeric name="dei:SolicitingMaterial" id="Fact_7cccb5f9da3d4c3399bf30d798d936e6" contextRef="c20241001to20241001" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric> Soliciting material pursuant to Rule 14a-12 under the Exchange
          Act (17 CFR 240.14a-12)</div>

        <div style="text-align: left; margin-bottom: 6.95pt; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementTenderOffer" id="Fact_1fc52929777e4b51a625aaaf4dd70c90" contextRef="c20241001to20241001" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric> Pre-commencement communications pursuant to Rule 14d-2(b) under
          the Exchange Act (17 CFR 240.14d-2(b))</div>

        <div style="text-align: left; margin-bottom: 2.05pt; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" id="Fact_877a69b0d679407b9ababaa44d5ab86e" contextRef="c20241001to20241001" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric> Pre-commencement communications pursuant to Rule 13e-4(c) under
          the Exchange Act (17 CFR 240.13e-4(c))</div>

        <div style="margin-bottom: 2.05pt; font-size: 10pt;">&#160;</div>

      </div>

      <div style="font-size: 10pt;"><span style="font-weight: bold;"> </span><br/>
      </div>

      <div style="text-align: center; font-size: 10pt;"><span style="text-decoration: underline;">Securities registered pursuant to Section 12(b) of the Act:</span></div>

      <div style="text-align: center; font-size: 10pt;"> <br/>
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="width: 100%; text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">


  <tr>

    <td style="width: 33.33%; vertical-align: top; font-size: 10pt; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; "><span style="text-decoration: underline;">Title of each class</span></div>
            </td>

    <td style="width: 33.33%; vertical-align: top; font-size: 10pt; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; "><span style="text-decoration: underline;">Trading Symbol(s)</span></div>
            </td>

    <td style="width: 33.33%; vertical-align: top; font-size: 10pt; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
              <div style="text-align: center; "><span style="text-decoration: underline;">Name of each exchange on which registered</span></div>
            </td>

  </tr>

  <tr>

    <td style="width: 33.33%; vertical-align: bottom; font-size: 10pt; text-align: center; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_88557b421be9437c83ad47e52930083b" contextRef="c20241001to20241001">Common Stock</ix:nonNumeric><br/>
            </td>

    <td style="width: 33.33%; vertical-align: bottom; font-size: 10pt; text-align: center; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_b536462fd8d646a7ba7ebb239654e0dc" contextRef="c20241001to20241001">FRPT</ix:nonNumeric><br/>
            </td>

    <td style="width: 33.33%; vertical-align: bottom; font-size: 10pt; text-align: center; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);"><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_237bd22b09de49d9bd61f08ead026971" contextRef="c20241001to20241001" format="ixt-sec:exchnameen">The NASDAQ Global Market</ix:nonNumeric><br/>
            </td>

  </tr>


</table>
      <div style="margin-top: 6pt; margin-bottom: 6pt; font-size: 10pt;"><br/>
      </div>

      <div><br/></div>

      <div style="text-align: left; font-size: 10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act
        of 1934 (&#167;240.12b-2 of this chapter):</div>

      <div><br/>
      </div>

      <div style="text-align: right; font-size: 10pt;">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_ba935a196fcf4006bdc1157b511f0d29" contextRef="c20241001to20241001" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></div>

      <div><br/>
      </div>

      <div style="text-align: left; font-size: 10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
        provided pursuant to Section 13(a) of the Exchange Act.&#160; &#9744;</div>

      <div style="text-align: left; font-size: 10pt;"> <br/>
      </div>

      <div style="text-align: left; font-size: 10pt;">
        <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"/> </div>

      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"/></div>

      </div>

      <div>
        <div>
          <div style="margin-top: 10pt;"><br/>
          </div>

          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 11.54%; vertical-align: top;">
                  <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 5.02.</div>
                </td>

    <td style="width: 88.46%; vertical-align: top;">
                  <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory
                    Arrangements of Certain Officers.</div>
                </td>

  </tr>


</table>
          <div><br/>
          </div>

          <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">At the 2024 Annual Meeting of Stockholders (the &#8220;Annual Meeting&#8221;) of Freshpet, Inc. (the &#8220;Company&#8221;) held on October 1, 2024 (the &#8220;Effective Date&#8221;)
            the Company&#8217;s stockholders approved the Freshpet, Inc. 2024 Equity Incentive Plan (the &#8220;2024 Equity Plan&#8221;). The full text of the 2024 Equity Plan as approved by the stockholders was filed as<span style="font-family: 'Times New Roman';"> Appendix B to the definitive proxy statement</span> filed by the Company with the Securities and Exchange Commission (the &#8220;SEC&#8221;) on August 22, 2024 (the &#8220;Proxy Statement&#8221;).</div>

          <div><br/>
          </div>

          <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The terms of the 2024 Equity Plan replace the terms of the Freshpet, Inc. Second Amended and Restated 2014 Omnibus Incentive Plan, as amended (the
            &#8220;Prior Plan&#8221;), and awards made under the 2024 Equity Plan will be made consistent with the terms of such plan. No additional grants will be made under the Prior Plan on or after the Effective Date. In addition, as of the Effective Date, the
            shares of the Company&#8217;s common stock, par value $0.001 per share (&#8220;Common Stock&#8221;) underlying the Prior Plan are longer available for grant, are not newly available under the 2024 Equity Plan and will be retired. Outstanding grants under the
            Prior Plan will continue to be in effect according to their terms.</div>

          <div><br/>
          </div>

          <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The 2024 Equity Plan is a long-term incentive plan, pursuant to which awards may be granted to employees, non-employee directors, and consultants
            of the Company or its subsidiaries, including stock options (including incentive stock options and non-qualified stock options), stock appreciation rights, stock awards, stock units, and other stock-based awards. As of the Effective Date, the
            2024 Equity Plan is the only plan under which new equity awards may be granted to the Company&#8217;s employees and other service providers.</div>

          <div><br/>
          </div>

          <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Subject to adjustment as described therein, the 2024 Equity Plan authorizes the issuance or transfer of up to 1,450,000 shares of Common Stock. As
            of the Effective Date, Common Stock underlying any outstanding award granted under the Prior Plan that expires, or is terminated, surrendered, cancelled, exchanged, or forfeited for any reason without issuance of such shares will be available
            for new grants under the 2024 Equity Plan. The 2024 Equity Plan also includes the following features: (i) no &#8220;evergreen&#8221; provision, meaning that the share reserve may not be increased without further stockholder approval; (ii) a cap on the
            maximum aggregate grant date value of Common Stock granted to any non-employee director in a calendar year, together with cash fees earned by such non-employee director during the year, that cannot exceed $750,000 in total value, subject to
            adjustment; (iii) provisions for eligibility, vesting and minimum vesting requirements; (iv) customary equitable adjustment provisions that the Compensation Committee (the &#8220;Committee&#8221;) of the Board of Directors of the Company&#160; (the &#8220;Board&#8221;) may
            undertake to adjust for certain corporate transactions, extraordinary events or to avoid dilution; (v) change of control provisions; and (vi) certain other features as described in the 2024 Equity Plan.</div>

          <div><br/>
          </div>

          <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Because future grants of awards under the 2024 Equity Plan are subject to the discretion of the Board or Committee, the amount and terms of future
            awards to particular participants or groups of participants are not determinable at this time.</div>

          <div><br/>
          </div>

          <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">This summary of the 2024 Equity Plan does not purport to be complete and is subject to, and qualified in its entirety, by reference to the full text
              of the 2024 Equity Plan, a copy of which is attached hereto as Exhibit 10.1 and incorporated herein by reference.</div>

          </div>

          <div style="margin-top: 10pt;"><br/>
          </div>

          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 11.54%; vertical-align: top;">
                  <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 5.07.</div>
                </td>

    <td style="width: 88.46%; vertical-align: top;">
                  <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Submission of Matters to a Vote of Security Holders.</div>
                </td>

  </tr>


</table>
          <div><br/>
          </div>

          <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">At the Annual Meeting, the Company&#8217;s stockholders considered four proposals, each of which is described in more detail in the Company&#8217;s Proxy
            Statement.&#160; The final results for each proposal presented at the Annual Meeting are set forth below:</div>

          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
            <div style="page-break-after: always;" class="BRPFPageBreak">
              <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

          </div>

          <div><br/>
          </div>

          <div><br/>
          </div>

          <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><a id="z_Hlk114064660"></a>(1) <span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Election of
              Directors. </span>All nominees were elected to serve on the Board of Directors pursuant to the following votes:</div>

          <div><br/>
          </div>

          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 26.24%; vertical-align: top;">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="text-decoration: underline;">DIRECTOR</span></div>
                </td>

    <td style="width: 24.25%; vertical-align: top;">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="text-decoration: underline;">FOR</span></div>
                </td>

    <td style="width: 28.77%; vertical-align: top;">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="text-decoration: underline;">AGAINST</span></div>
                </td>

    <td style="width: 20.73%; vertical-align: top;">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="text-decoration: underline;">ABSTAIN</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.24%; vertical-align: top;">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">David B. Biegger</div>
                </td>

    <td style="width: 24.25%; vertical-align: top;">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">41,165,011</div>
                </td>

    <td style="width: 28.77%; vertical-align: top;">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">137,349</div>
                </td>

    <td style="width: 20.73%; vertical-align: top;">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">26,866</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.24%; vertical-align: top;">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Daryl G. Brewster</div>
                </td>

    <td style="width: 24.25%; vertical-align: top;">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">40,266,863</div>
                </td>

    <td style="width: 28.77%; vertical-align: top;">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1,036,823</div>
                </td>

    <td style="width: 20.73%; vertical-align: top;">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">25,540</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.24%; vertical-align: top;">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Jacki S. Kelley</div>
                </td>

    <td style="width: 24.25%; vertical-align: top;">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">40,464,663</div>
                </td>

    <td style="width: 28.77%; vertical-align: top;">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">775,536</div>
                </td>

    <td style="width: 20.73%; vertical-align: top;">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">89,027</div>
                </td>

  </tr>

  <tr>

    <td style="width: 26.24%; vertical-align: top;">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Timothy R. McLevish</div>
                </td>

    <td style="width: 24.25%; vertical-align: top;">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">41,119,866</div>
                </td>

    <td style="width: 28.77%; vertical-align: top;">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">138,996</div>
                </td>

    <td style="width: 20.73%; vertical-align: top;">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">70,364</div>
                </td>

  </tr>


</table>
          <div><br/>
          </div>

          <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">There were 2,856,494 broker non-votes with respect to this matter.</div>

          <div><br/>
          </div>

          <div><br/>
          </div>

          <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(2) <span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Approval of the 2024 Equity Incentive
              Plan. </span>The 2024 Equity Incentive Plan proposal was approved with the following votes:</div>

          <div><br/>
          </div>

          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 33.33%; vertical-align: top;">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="text-decoration: underline;">FOR</span></div>
                </td>

    <td style="width: 33.33%; vertical-align: top;">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="text-decoration: underline;">AGAINST</span></div>
                </td>

    <td style="width: 33.33%; vertical-align: top;">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="text-decoration: underline;">ABSTAIN</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 33.33%; vertical-align: top;">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">40,170,850</div>
                </td>

    <td style="width: 33.33%; vertical-align: top;">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">1,132,674</div>
                </td>

    <td style="width: 33.33%; vertical-align: top;">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">25,702</div>
                </td>

  </tr>


</table>
          <div><br/>
          </div>

          <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">There were 2,856,494 broker non-votes with respect to this matter.</div>

          <div><br/>
          </div>

          <div><br/>
          </div>

          <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(3) <span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Ratification of Appointment of
              Independent Registered Public Accounting Firm. </span>The appointment of KPMG LLP as the Company&#8217;s independent registered public accounting firm for 2024 was ratified with the following votes:</div>

          <div><br/>
          </div>

          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 33.33%; vertical-align: top;">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="text-decoration: underline;">FOR</span></div>
                </td>

    <td style="width: 33.33%; vertical-align: top;">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="text-decoration: underline;">AGAINST</span></div>
                </td>

    <td style="width: 33.33%; vertical-align: top;">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="text-decoration: underline;">ABSTAIN</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 33.33%; vertical-align: top;">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">43,896,020</div>
                </td>

    <td style="width: 33.33%; vertical-align: top;">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">263,293</div>
                </td>

    <td style="width: 33.33%; vertical-align: top;">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">26,407</div>
                </td>

  </tr>


</table>
          <div><br/>
          </div>

          <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">There were no broker non-votes with respect to this matter.</div>

          <div><br/>
          </div>

          <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(4) <span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Approval, by Non-Binding Advisory Vote,
              of the Compensation of the Company&#8217;s Named Executive Officers. </span>The Say-on-Pay advisory proposal to approve executive compensation was approved with the following votes:</div>

          <div><br/>
          </div>

          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 33.33%; vertical-align: top;">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="text-decoration: underline;">FOR</span></div>
                </td>

    <td style="width: 33.33%; vertical-align: top;">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="text-decoration: underline;">AGAINST</span></div>
                </td>

    <td style="width: 33.33%; vertical-align: top;">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="text-decoration: underline;">ABSTAIN</span></div>
                </td>

  </tr>

  <tr>

    <td style="width: 33.33%; vertical-align: top;">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">40,404,958</div>
                </td>

    <td style="width: 33.33%; vertical-align: top;">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">890,056</div>
                </td>

    <td style="width: 33.33%; vertical-align: top;">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">34,212</div>
                </td>

  </tr>


</table>
          <div><br/>
          </div>

          <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">There were 2,856,494 broker non-votes with respect to this matter.</div>

          <div><br/>
          </div>

          <div><br/>
          </div>

          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 11.54%; vertical-align: top;">
                  <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 5.08.</div>
                </td>

    <td style="width: 88.46%; vertical-align: top;">
                  <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Shareholder Director Nominations.</div>
                </td>

  </tr>


</table>
          <div><br/>
          </div>

          <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">At the Annual Meeting, the Board determined that the Company&#8217;s 2025 Annual Meeting of Stockholders (the &#8220;2025 Annual Meeting&#8221;) will be held on June
            24, 2025, at 9:00 a.m., Eastern Time. The time and location of the 2025 Annual Meeting, as well as the record date for the determination of stockholders entitled to receive notice of and to vote at the 2025 Annual Meeting, will be as set forth
            in the Company&#8217;s definitive proxy statement for the 2025 Annual Meeting to be filed with the SEC.</div>

          <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

          <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Due to the fact that the date of the 2025 Annual Meeting has been changed by more than 30 days from the anniversary date of the 2024 Annual
            Meeting, the Company is providing the due date for submission of any qualified stockholder proposal or qualified stockholder nominations.</div>

          <div style="text-align: justify; margin-top: 12pt; margin-bottom: 12pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Nomination



              of Director Candidates:</span><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">&#160; </span>Our Company&#8217;s Amended and Restated Bylaws (the &#8220;Bylaws&#8221;) provide that in the event that the date of the 2025 Annual
            Meeting is more than 30 days before or more than 60 days after the anniversary date of the 2024 Annual Meeting, then pursuant to our Bylaws, notice by a stockholder must be delivered to us no earlier than the close of business on the 120th day
            prior to the 2025 Annual Meeting and no later than the later of (i) the close of business on the 90th day prior to the 2025 Annual Meeting and (ii) the close of business on the</div>

          <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
            <div style="page-break-after: always;" class="BRPFPageBreak">
              <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

          </div>

          <div><br/>
          </div>

          <div style="text-align: justify; margin-top: 5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">10th day following the date on which public announcement of the date of the 2025 Annual Meeting is first made. The notice must
            contain the information required by, and otherwise comply with, our Bylaws, and should be addressed to: Freshpet, Inc., 1545 US-206, Bedminster, NJ 07921, Attention: Corporate Secretary.&#160; As a result, you must deliver notice of a nomination to
            us no earlier than the close of business on February 24, 2025 and no later than the close of business on March 26, 2025 in order to nominate a candidate for election to the Board at our 2025 Annual Meeting.</div>

          <div style="text-align: justify; margin-top: 12pt; margin-bottom: 12pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Universal



              Proxy Rules</span>: In addition to satisfying the foregoing requirements under our Bylaws, to comply with the universal proxy rules, stockholders who intend to solicit proxies in support of director nominees other than our nominees must
            provide notice that sets forth the information required by Rule 14a-19 under the Exchange Act no later than April 25, 2025, which date is the later of 60 calendar days prior to the date of the 2025 Annual Meeting or the 10th calendar day
            following public announcement by the Company of the date of the 2025 Annual Meeting.</div>

          <div style="text-align: justify; margin-top: 12pt; margin-bottom: 12pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Proxy
              Access</span>: Under the Company&#8217;s proxy access Bylaws provision, a stockholder or a group of no more than twenty (20) stockholders owning three percent (3%) or more of the voting power of the Company's outstanding capital stock continuously
            for at least three (3) years may nominate and include in the Company's proxy statement for an annual meeting director nominees constituting up to the greater of two (2) individuals or twenty percent (20%) of the number of directors in office,
            provided the stockholders satisfy the requirements specified in the Bylaws. To be timely for the 2025 Annual Meeting, such nominations must be submitted in writing and received by our Corporate Secretary no earlier than the close of business on
            December 1, 2024 and no later than the close of business on December 31, 2024.</div>

          <div style="text-align: justify; margin-top: 12pt; margin-bottom: 12pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Rule
              14a-8 Stockholder Proposals</span><span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">:</span> To be considered for inclusion in our proxy statement for the 2025 Annual Meeting pursuant to Rule 14a-8 under the
            Exchange Act, the Company must receive notice of a stockholder proposal on or before December 31, 2024, which the Company has determined to be a reasonable time before it expects to begin to print and send its proxy materials in accordance with
            Rule 14a-5(f) and Rule 14a-8(e) under the Securities Exchange Act of 1934, as amended. The proposal must comply with the SEC rules regarding eligibility for inclusion in our proxy statement, and should be addressed to: Freshpet, Inc., 1545
            US-206, Bedminster, NJ 07921, Attention: Corporate Secretary.</div>

          <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Non-Rule 14a-8 Stockholder Proposals</span><span style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">:</span> If you intend to present a proposal at an annual meeting other than by submitting a stockholder proposal for inclusion in our proxy statement for that
            meeting pursuant to Rule 14a-8 under the Exchange Act, our Bylaws require you to give notice at least 90 days, but no more than 120 days, prior to the date of the 2025 Annual Meeting. As a result, in order to present a proposal in this manner
            at the 2025 Annual Meeting, you must deliver notice of a proposal to us no earlier than the close of business on February 24, 2025 and no later than the close of business on March 26, 2025 in order to present it at the 2025 Annual Meeting. The
            notice must contain the information required by, and otherwise comply with, our Bylaws, and should be addressed to: Freshpet, Inc., 1545 US-206, Bedminster, NJ 07921, Attention: Corporate Secretary.</div>

          <div><br/>
          </div>

          <div><br/>
          </div>

          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 11.54%; vertical-align: top;">
                  <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 9.01.</div>
                </td>

    <td style="width: 88.46%; vertical-align: top;">
                  <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Financial Statements and Exhibits.</div>
                </td>

  </tr>


</table>
          <div><br/>
          </div>

          <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(d)&#160; Exhibits.</div>

          <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>

          <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 16.38%; vertical-align: bottom; border-bottom: #000000 1.50pt solid;">
                  <div style="text-align: justify; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exhibit No.</div>
                </td>

    <td style="width: 5.26%; vertical-align: bottom;">
                  <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#160;</div>
                </td>

    <td style="width: 78.36%; vertical-align: bottom; border-bottom: #000000 1.50pt solid;">
                  <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Description of Exhibit</div>
                </td>

  </tr>

  <tr>

    <td style="width: 16.38%; vertical-align: top;">
                  <div style="text-align: center; margin-right: 31.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><a href="exhibit10-1.htm">10.1*</a></div>
                </td>

    <td style="width: 5.26%; vertical-align: bottom;"><br/>
                </td>

    <td style="width: 78.36%; vertical-align: top;">
                  <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><a href="exhibit10-1.htm">Freshpet, Inc. 2024 Equity
                      Incentive Plan <br/>
                    </a></div>
                </td>

  </tr>

  <tr>

    <td style="width: 16.38%; vertical-align: top;">
                  <div style="text-align: center; margin-right: 31.5pt; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><a href="frpt-20241001.xsd">104</a></div>
                </td>

    <td style="width: 5.26%; vertical-align: bottom;"> <br/>
                </td>

    <td style="width: 78.36%; vertical-align: top;">
                  <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><a href="frpt-20241001.xsd">Cover Page Interactive Data File
                      (embedded within the Inline XBRL document)</a></div>
                </td>

  </tr>


</table>
          <div> __________________<br/>
          </div>

          <div>
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">* Exhibits marked with an asterisk are filed herewith.</div>

          </div>

          <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
            <div class="BRPFPageBreak" style="page-break-after: always;">
              <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

          </div>

          <div style="text-align: center; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">SIGNATURE</div>

          <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>

          <div style="text-align: left; text-indent: 23.1pt; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to
            be signed on its behalf by the undersigned hereunto duly authorized.</div>

          <div><br/>
          </div>

          <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 49.96%; vertical-align: top;">
                  <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td style="vertical-align: top;" colspan="2">
                  <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">FRESHPET, INC.</div>
                </td>

  </tr>

  <tr>

    <td style="width: 49.96%; vertical-align: top;">
                  <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td style="vertical-align: top;" colspan="2">
                  <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

  </tr>

  <tr>

    <td style="width: 49.96%; vertical-align: top;">
                  <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Date: October 4, 2024</div>
                </td>

    <td style="width: 2%; vertical-align: top; white-space: nowrap;">
                  <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">By:&#160; <br/>
                  </div>
                </td>

    <td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 48%;">
                  <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;/s/ Todd Cunfer</div>
                </td>

  </tr>

  <tr>

    <td style="width: 49.96%; vertical-align: top;">
                  <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td style="vertical-align: top;" colspan="2">
                  <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Name: Todd Cunfer</div>
                </td>

  </tr>

  <tr>

    <td style="width: 49.96%; vertical-align: top;">
                  <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;</div>
                </td>

    <td style="vertical-align: top;" colspan="2">
                  <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Title: Chief Financial Officer</div>
                </td>

  </tr>


</table>
          <div><br/>
          </div>

        </div>

        <div><br/>
        </div>

        <div><br/>
        </div>

        <div><br/>
          <br/>
        </div>

        <div><br/></div>

      </div>

    </div>

  </div>

</div>
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>exhibit10-1.htm
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Morgan Lewis
         Document created using Broadridge PROfile 24.8.1.5246
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <!--PROfilePageNumberReset%Num%1%%%-->
  <div style="text-align: right;"><font style="font-weight: bold;">Exhibit 10.1</font><br>
  </div>
  <div><br>
  </div>
  <div><br>
  </div>
  <br>
  <div style="text-align: center; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><a name="z_Hlk117609080"></a><a name="z_Hlk121318059"></a><a name="z_Hlk128427004"></a>FRESHPET, INC.<font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
      </font>2024 EQUITY INCENTIVE PLAN<font style="font-size: 10pt; font-family: 'Times New Roman';"><br>
      </font></font><br>
  </div>
  <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Section 1.&#160; &#160; &#160; Effectiveness and Purpose</font>.</div>
  <div style="text-align: left; text-indent: 36pt; margin-bottom: 6pt; font-family: 'Times New Roman'; font-size: 10pt;">Effective as of the Effective Date, the <a name="z_9kR3WTr2664CEQKl1DEHUQD66NnXyq2IEHEjl36"></a><a name="z_Hlk117609130"></a>Freshpet,
    Inc. 2024 Equity Incentive Plan (as may be amended f<a name="z_9kR3WTr2664BIVKl1DEHUQD66NnXyq2IEHEjl36"></a>rom time to time, the &#8220;<a name="z_9kR3WTr2444ELcPhk"></a><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Plan</u></font>&#8221;)
    is hereby established.</div>
  <div style="text-align: left; text-indent: 36pt; margin-bottom: 6pt; font-family: 'Times New Roman'; font-size: 10pt;">The purpose of the Plan is to provide <a name="z_9kMHG5YVt4666ENVHzzzD4l"></a>employees of <a name="z_Hlk117609112"></a>Freshpet,
    Inc., a Delaware corporation (together with its successors, the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Company</u></font>&#8221;), and its Subsidiaries, certain consultants and advisors who perform services for
    the Company or its Subsidiaries, and non-<a name="z_9kMIH5YVt4666ENVHzzzD4l"></a>employee members of the Board, with the opportunity to receive <a name="z_9kMHG5YVt4666FLUOpm6"></a>grants of equity awards in the form of <a name="z_9kMHG5YVt4666FMXMnfr7363blEyviiKEAG"></a>incentive stock options, <a name="z_9kMHG5YVt4666FNdSz2AvnwrssodoH1yllNHDJ"></a>nonqualified stock options, stock appreciation rights, <a name="z_9kMHG5YVt4666FOjc5pmLSzvz"></a>stock awards, <a name="z_9kMHG5YVt4666FPkc5pmfdy5"></a>stock units, and <a name="z_9kMHG5YVt4666GHXYykvkhAurRC05rOc959"></a>other stock-based awards.&#160; Capitalized terms used in the Plan and not otherwise defined herein shall have the meaning assigned to them in
    Section&#160;2.</div>
  <div style="text-align: left; text-indent: 36pt; margin-bottom: 6pt; font-family: 'Times New Roman'; font-size: 10pt;">The Plan is to enhance the profitability and value of the Company for the benefit of its stockholders by enabling the Company to offer
    eligible participants with stock-based and/or cash-based incentives in order to attract, retain and reward such individuals and strengthen the mutuality of interests between such individuals and the Company&#8217;s stockholders.</div>
  <div style="text-align: left; text-indent: 36pt; margin-bottom: 6pt; font-family: 'Times New Roman'; font-size: 10pt;">The Plan is intended to replace the Prior Plan.&#160; No additional grants shall be made under the Prior Plan on or after the Effective
    Date.&#160; Outstanding <a name="z_9kMIH5YVt4666FLUOpm6"></a>grants under the Prior Plan shall continue in effect according to their terms.</div>
  <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman'; font-size: 10pt;"><a name="z_Toc64352017"></a><a name="z_Ref_ContractCompanion_9kb9Ur013"></a><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Section 2.&#160; &#160; &#160; Definitions</font><font style="font-size: 10pt; font-family: 'Times New Roman';">.</font></div>
  <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman'; font-size: 10pt;">The following terms shall have the meanings set forth below for purposes of the Plan:</div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8220;<a name="z_9kR3WTr2444EOQ4gkrsiuz"></a><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Affiliate</u></font>&#8221; means, when used with reference to any Person,
      any other Person that directly or indirectly, through one or more intermediaries, controls, is controlled by or is under common control with, or owns greater than 50% of the voting power in, the specified Person (the term &#8220;control&#8221; for this purpose
      means the ability, whether by the ownership of shares or other equity interest, by contract or otherwise, to elect a majority of the directors of a corporation, independently to select the managing partner of a partnership or the managing member or
      the majority of the managers, as applicable, of a limited liability <a name="z_9kMHG5YVt4666GIMHy0poD"></a>company, or otherwise to have the power independently to remove and then select a majority of those Persons exercising governing authority
      over an entity, and control shall be conclusively presumed in the case of the direct or indirect ownership of 50% or more of the voting equity interests in the specified Person).</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Award</u></font>&#8221; means an Option, SAR, Stock Award, Stock Unit or Other Stock-Based Award granted under
      the Plan.</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Award Agreement</u></font>&#8221; means the written agreement that sets forth the terms and conditions of an
      Award, including all amendments thereto.</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(d)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8220;<a name="z_9kR3WTr2444EJMEkos"></a><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Board</u></font>&#8221; means the Board of Directors of the Company.</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(e)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Cause</u></font>&#8221;, for any particular <font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">Participant</font> has the meaning ascribed thereto in any effective written employment agreement between such <font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">Participant</font> and the Company or one of
      its Affiliates, or, if no employment agreement is in effect that contains a definition of &#8220;Cause&#8221;, then <a name="z_9kMHG5YVt3BC7AJU3sBw"></a>Cause means any <font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">one of the
        following reasons for the discharge or other separation of a Participant from employment or services</font>:</font></div>
  <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman',Times,serif; font-size: 8pt; font-weight: normal; font-style: normal;">1</font></div>
    <div class="BRPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div style="margin-bottom: 8pt;"><br>
  </div>
  <div style="text-align: left; text-indent: 72pt; margin-left: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #232323;">(i)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 6pt;">&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #232323;">fraud (</font>including<font style="font-size: 10pt; font-family: 'Times New Roman'; color: #232323;"> but not
        limited to any acts of embezzlement or misappropriation of funds) with respect to the Company and its Affiliates;</font></font></div>
  <div style="text-align: left; text-indent: 72pt; margin-left: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #232323;">(ii)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #232323;">serious dereliction of fiduciary obligation with respect to the Company and its Affiliates;</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-left: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #232323;">(iii)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #232323;">conviction of a felony, plea of guilty or nolo contendere to a felony charge or any criminal act involving moral turpitude (which, through
      lapse of time or otherwise, is not subject to appeal);</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-left: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #232323;">(iv)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #232323;">repeatedly being under the influence of drugs or alcohol (other than prescription medicine or other medically-related drugs to the extent that
      they are taken in accordance with their directions) during the performance of the Participant&#8217;s duties with respect to the Company and its Affiliates;</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-left: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #232323;">(v)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #232323;">a material and willful failure to perform the </font><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">Participant&#8217;s </font><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #232323;">duties with respect to the Company and its Affiliates;</font></font></div>
  <div style="text-align: left; text-indent: 72pt; margin-left: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #232323;">(vi)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #232323;">willful misconduct or gross negligence or other conduct that would reasonably be
        expected to result in material injury or reputational harm to </font>the Company or one of its Affiliates<font style="font-size: 10pt; font-family: 'Times New Roman'; color: #232323;">; or</font></font></div>
  <div style="text-align: left; text-indent: 72pt; margin-left: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #232323;">(vii)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #232323;">material breach of any </font><a name="z_9kMHG5YVt4667BIhMuAA0my585NSI92z0KQ"></a><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #232323;">restrictive covenant agreement or other material agreement entered into between the </font><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">Participant
      </font><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #232323;">and </font>the Company or one of its Affiliates<font style="font-size: 10pt; font-family: 'Times New Roman'; color: #232323;">, or a violation of the Company&#8217;s
        written </font><a name="z_9kMHG5YVt4667BJTHpg"></a><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #232323;">code of conduct or any other written policy of </font>the Company or one of its Affiliates<font style="font-size: 10pt; font-family: 'Times New Roman'; color: #232323;">, both as provided to the </font><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">Participant </font><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #232323;">before the alleged breach.</font></font></div>
  <div style="text-align: left; margin-bottom: 12pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #232323;">Anything herein to the contrary notwithstanding, the Company shall give
      the </font><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">Participant </font><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #232323;">written notice prior to a termination for Cause based upon
      the foregoing clauses (i), (iv), (v), or (vii) above, which notice shall set forth the exact nature of the alleged conduct and the conduct required to cure such conduct, if the Company determines that the conduct is curable.&#160; The </font><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">Participant </font><font style="font-size: 10pt; font-family: 'Times New Roman'; color: #232323;">shall have thirty (30) days from the giving of such notice within which to
      cure the applicable conduct to the satisfaction of the Company.</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(f)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8220;<a name="z_9kR3WTr19A566J8dkrjmwRN5BGC7"></a><a name="z_9kR3WTr19A56AN8dkrjmwRN5BGC7"></a><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Change in Control</u></font>&#8221;
      <a name="z_9kR3WTrAG845AdLcszv1GvpMMHK14JHD06PSD1J"></a>means a change in ownership or control of the Company effected through any of the following transactions:</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-left: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(i)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 6pt;">&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';">any &#8220;person,&#8221; as such term is used in Sections 13(d) and 14(d) of the Exchange Act (other than the Company, any trustee or other fiduciary holding securities under any employee benefit plan of
      the Company, or any company owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions as their ownership of Common Stock of the Company), becoming the beneficial owner (as defined in Rule 13d-3 under the
      Exchange Act), directly or indirectly, of securities of the Company representing <font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">50% or more</font> of the combined voting power of the Company&#8217;s then outstanding
      securities;</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-left: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ii)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';">during any one-year period, individuals who at the beginning of such period constitute the Board, and any new director (other than a director designated by a Person who has entered into an
      agreement with the Company to effect a transaction that would otherwise constitute a Change in Control or a director whose initial assumption of office occurs as a result of either an actual or threatened election contest (as such term is used in
      Rule 14a-11 of Regulation 14A promulgated under the Exchange Act) or other actual or threatened solicitation of proxies or consents by or on behalf of a Person other than the Board) whose election by the Board or nomination for election by the
      Company&#8217;s stockholders was approved by a vote of at least two-thirds of the directors then still in</font></div>
  <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: normal; font-style: normal;">2</font></div>
    <div class="BRPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div style="margin-bottom: 8pt;"><br>
  </div>
  <div style="text-align: left; margin-left: 72pt; margin-bottom: 12pt; font-family: 'Times New Roman'; font-size: 10pt;">office who either were directors at the beginning of the one-year period or whose election or nomination for election was previously
    so approved, cease for any reason to constitute at least a majority of the Board;</div>
  <div style="text-align: left; text-indent: 72pt; margin-left: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(iii)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';">a merger or consolidation of the Company with any other corporation, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately
      prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) <font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">50% or more</font> of the
      combined voting power of the voting securities of the Company or such surviving entity outstanding immediately after such merger or consolidation; provided, however, that a merger or consolidation effected to implement a recapitalization of the
      Company (or similar transaction) in which no Person (other than those covered by the exceptions in paragraph (i) above) acquires more than 50% of the combined voting power of the Company&#8217;s then outstanding securities shall not constitute a Change in
      Control of the Company; or</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-left: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(iv)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';">a complete liquidation or dissolution of the Company or the consummation of a sale or disposition by the Company of all or substantially all of the Company&#8217;s assets, other than the sale or
      disposition of all or substantially all of the assets of the Company to a Person or Persons who beneficially own, directly or indirectly, <font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">50% or more</font> of the
      combined voting power of the outstanding voting securities of the Company at the time of the sale.</font></div>
  <div style="text-align: left; margin-bottom: 12pt; font-family: 'Times New Roman'; font-size: 10pt;">The Committee may modify the definition of Change in Control for a particular Award as the Committee deems necessary or appropriate to comply with
    Section&#160;409A of the Code.&#160; Notwithstanding the foregoing, if an Award constitutes deferred compensation subject to Section&#160;409A of the Code and the Award provides for payment upon a Change in Control, then, for purposes of such payment provisions, no
    Change in Control shall be deemed to have occurred upon an event described in <a name="z_9kMHG5YVtCIA67CfNeu1x3IxrOOJM36LJF28RUF"></a>items (i)-(iv) above unless the event would also constitute a change in ownership or effective control of, or a
    change in the ownership of a substantial portion of the assets of, the Company under Section&#160;409A of the Code.</div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(g)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Code</u></font>&#8221; means the Internal Revenue Code of 1986, as amended, and the regulations promulgated
      thereunder.</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(h)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Committee</u></font>&#8221; means the <a name="z_9kR3WTr2664BLSFwyrq5tv406VR874COAw"></a>Compensation Committee
      of the Board or another committee appointed by the Board to administer the Plan.&#160; The Committee shall consist of directors who are &#8220;<a name="z_9kMHG5YVt4666GMbSzQK222G7oON85r7KJ"></a>non-employee directors&#8221; as defined under Rule 16b-3 promulgated
      under the Exchange Act and &#8220;independent directors,&#8221; as determined in accordance with the independence standards established by the stock exchange on which the Common Stock is at the time primarily traded.</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(i)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Common Stock</u></font>&#8221; means common stock, par value $.001 per share, of the Company, and such other
      securities as may be substituted for Common Stock pursuant to <a name="z_9kMHG5YVtCIA6AFfNeu1x3LyZm21KBCPQBTgD9D"></a>Section 5(c) or Section&#160;5(e).</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(j)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Disability</u></font>&#8221; or &#8220;<a name="z_9kR3WTr1AB4CFMAwpZlpi"></a><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Disabled</u></font>&#8221; has the meaning set forth in an applicable Award Agreement or written employment or services agreement with a Participant, and in the absence of the forgoing, means (i)&#160;the
      Participant&#8217;s becoming disabled within the meaning of the Employer&#8217;s <a name="z_Hlk129959724"></a>long&#8209;term disability <a name="z_9kMHG5YVt4666GNeRjm"></a>plan applicable to the Participant, or (ii)&#160;if no long&#8209;term disability plan is applicable to
      the Participant, the Participant&#8217;s inability to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment that is expected to result in death or has lasted or can be expected to last for a
      continuous period of six months or more, consistent with Section 409A of the Code.</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(k)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Dividend Equivalent</u></font>&#8221; means an amount determined by multiplying the number of shares of Common
      Stock subject to a Stock Unit or Other Stock-Based Award by the per-share cash</font></div>
  <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: normal; font-style: normal;">3</font></div>
    <div class="BRPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div style="margin-bottom: 8pt;"><br>
  </div>
  <div style="text-align: left; margin-bottom: 12pt; font-family: 'Times New Roman'; font-size: 10pt;">dividend paid by the Company on its outstanding Common Stock, or the per-share Fair Market Value of any dividend paid on its outstanding Common Stock in
    consideration other than cash.&#160; No interest shall be credited on accumulated divided equivalents.</div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(l)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Effective Date</u></font>&#8221; means the date the Plan is approved by the Company&#8217;s stockholders.</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(m)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8220;<a name="z_9kR3WTr2334EMSFxxxB2ig2GACDDIDwx87DCCUM"></a><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Employed by, or providing service to, the Employer</u></font>&#8221;
      means employment or service as an Employee, Key Advisor or member of the Board (so that, for purposes of exercising Options and SARs and satisfying conditions with respect to Stock Awards, Stock Units, and Other Stock-Based Awards, a Participant
      shall not be considered to have terminated employment or service until the Participant ceases to be an Employee, Key Advisor and member of the Board), unless the Committee determines otherwise.&#160; If a Participant&#8217;s relationship is with a Subsidiary
      and that entity ceases to be a Subsidiary, the Participant will be deemed to cease employment or service when the entity ceases to be a Subsidiary, unless the Participant transfers employment or service to an Employer.&#160; If a Participant has military,
      sick leave or other bona fide leave, the Participant will not be deemed to cease employment or service solely as a result of such leave; <font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">provided</font> that such
      leave does not exceed the longer of 90 days or the period during which the absent Participant&#8217;s reemployment rights, if any, are guaranteed by statute or contract.&#160; To the extent consistent with applicable law, the Committee may provide that Awards
      continue to vest for all or a portion of the period of such leave, or that vesting shall be tolled during such leave and only recommence upon the Participant&#8217;s return from such leave.</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(n)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8220;<a name="z_9kR3WTr2444CLTFxxxB2j"></a><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Employee</u></font>&#8221; means an employee of the Employer (including an
      officer or director who is also an employee), but excluding any person who is classified by the Employer as a &#8220;contractor&#8221; or &#8220;consultant,&#8221; no matter how characterized by the Internal Revenue Service, other governmental agency or a court.&#160; Any change
      of characterization of an individual by the Internal Revenue Service or any court or government agency shall have no effect upon the classification of an individual as an Employee for purposes of this Plan, unless the Committee determines otherwise.</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><a name="z_9kR3WTr2554CMUFxxxB2ig2GACDDIDwx87DCCUM"></a><font style="font-size: 10pt; font-family: 'Times New Roman';">(o)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8220;<a name="z_9kR3WTr2444DFMFxxxB2w"></a><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Employer</u></font>&#8221;
      means the Company and its Subsidiaries.</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(p)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Exchange Act</u></font>&#8221; means the Securities Exchange Act of 1934, as amended.</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(q)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Exercise Price</u></font>&#8221; means the per share price at which shares of Common Stock may be purchased under
      an Option, as designated by the Committee.</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(r)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8220;<a name="z_9kR3WTr2444EHO4ewbFr2q0sUrC6"></a><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Fair Market Value</u></font>&#8221; means:</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-left: 36pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(i)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';">If the Common Stock is publicly traded, the Fair Market Value per share shall be determined as follows: (A) if the principal trading market for the Common Stock is a national securities
      exchange, the closing sales price during regular trading hours on the relevant date or, if there were no trades on that date, the latest preceding date upon which a sale was reported, or (B) if the Common Stock is not principally traded on any such
      exchange, the last reported sale price of a share of Common Stock during regular trading hours on the relevant date, as reported by the OTC Bulletin Board.</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-left: 36pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ii)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';">If the Common Stock is not publicly traded or, if publicly traded, is not subject to reported transactions as set forth above, the Fair Market Value per share shall be determined by the
      Committee through any reasonable valuation method authorized under the Code.<a name="z_9kR3WTr1AB4CGQfaq"></a></font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(s)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8220;<a name="z_9kR3WTr2444DKVKldp5141ZjCwtggIC8E"></a><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Incentive Stock Option</u></font>&#8221; means an Option that
      is intended to meet the requirements of an incentive stock <a name="z_9kMHG5YVt4666GPfU60w2"></a>option under Section 422 of the Code.</font></div>
  <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: normal; font-style: normal;">4</font></div>
    <div class="BRPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div style="margin-bottom: 8pt;"><br>
  </div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(t)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Key Advisor</u></font>&#8221; means a consultant or advisor of the Employer.</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(u)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8220;<a name="z_9kR3WTr2444EKZQxOI000E5mML63p5IH"></a><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Non-Employee Director</u></font>&#8221; means a member of the
      Board who is not an Employee.</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(v)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8220;<a name="z_9kR3WTr2444DLbQx08tlupqqmbmFzwjjLFBH"></a><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Nonqualified Stock Option</u></font>&#8221; means an Option
      that is not intended to be taxed as an <a name="z_9kMIH5YVt4666FMXMnfr7363blEyviiKEAG"></a>incentive stock option under Section 422 of the Code.</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(w)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8220;<a name="z_9kR3WTr2444ENdS4yu0"></a><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Option</u></font>&#8221; means an option to purchase shares of Common Stock,
      as described in Section&#160;7.</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(x)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8220;<a name="z_9kR3WTr2444EFVWwitif8spPAy3pMa737"></a><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Other Stock-Based Award</u></font>&#8221; means any Award based
      on, measured by or payable in Common Stock (other than an Option, Stock Unit, Stock Award, or SAR), as described in <a name="z_9kMHG5YVtCIA6AEeNeu1x3HJhh7t4tqJ30aL9E0"></a>Section&#160;11.</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(y)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Participant</u></font>&#8221; means an Employee, Key Advisor or Non-Employee Director designated by the Committee
      to participate in the Plan.</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(z)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8220;<a name="z_9kR3WTr2444DIaIrtr43npskPUvtC"></a><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Performance Goals</u></font>&#8221; means the business criteria
      selected by the Company to measure the level of performance of the Company or an <a name="z_9kMHG5YVt4666GQS6imtukw1"></a>Affiliate during a performance period, which may include, but are not limited to, one or more of the following criteria:
      earnings per share; operating income; gross income; net income (before or after taxes); cash flow; gross profit; gross profit return on investment; gross margin return on investment; gross margin; operating margin; working capital; earnings before
      interest and taxes; earnings before interest, tax, depreciation and amortization; return on equity; return on assets; return on capital; return on invested capital; net revenues; gross revenues; revenue growth; annual recurring revenues; recurring
      revenues; license revenues; sales or market share; total stockholder return; economic value added; specified objectives with regard to limiting the level of increase in all or a portion of the Company&#8217;s bank debt or other long-term or short-term
      public or private debt or other similar financial obligations of the Company, which may be calculated net of cash balances and/or other offsets and adjustments as may be established by the Committee in its sole discretion; the fair market value of a
      share of Common Stock; the growth in the value of an investment in the Common Stock assuming the reinvestment of dividends; reduction in operating expenses; strategic goals or objectives (including objectives related to qualitative or quantitative
      environmental, social or governance metrics); and other applicable criteria as determined by the Committee.<a name="z_9kMHG5YVt4666FKcKtvt65prumRWxvE"></a></font></div>
  <div style="text-align: left; margin-bottom: 12pt; font-family: 'Times New Roman'; font-size: 10pt;">Performance Goals applicable to an Award shall be determined by the Committee, and may be established on an absolute or relative basis and may be
    established on a corporate-wide basis or with respect to one or more business units, divisions, subsidiaries or business segments.&#160; Relative performance may be measured against a group of peer <a name="z_9kMIH5YVt4666GIMHy0poD"></a>companies, a
    financial market index or other objective and quantifiable indices.</div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(aa)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8220;<a name="z_9kR3WTr2444EIZIr640"></a><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Person</u></font>&#8221; means any natural person, corporation, limited
      liability <a name="z_9kMJI5YVt4666GIMHy0poD"></a>company, partnership, trust, joint stock <a name="z_9kMKJ5YVt4666GIMHy0poD"></a>company, business trust, unincorporated association, joint venture, governmental authority or other legal entity of any
      nature whatsoever.</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(bb)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Prior Plan</u></font>&#8221; means the Freshpet, Inc. Second Amended and Restated 2014 Omnibus Incentive Plan, as
      amended through the Effective Date.</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(cc)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>SAR</u></font>&#8221; means a stock appreciation right, as described in <a name="z_9kMHG5YVtCIA6ABbNeu1x3HIklEyvUUGJ9v0zBK"></a>Section&#160;10.</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(dd)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8220;<a name="z_9kR3WTr2444DMha3nkJQxtx"></a><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Stock Award</u></font>&#8221; means an award of Common Stock, as
      described in <a name="z_9kMHG5YVtCIA6BDcNeu1x3OrkDxuTa7379"></a>Section&#160;8.</font></div>
  <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: normal; font-style: normal;">5</font></div>
    <div class="BRPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div style="margin-bottom: 8pt;"><br>
  </div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ee)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8220;<a name="z_9kR3WTr2444DNia3nkdbw3"></a><font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Stock Unit</u></font>&#8221; means an award of a contractual right to
      receive one or more shares of Common Stock, cash or combination thereof, as described in <a name="z_9kMHG5YVtCIA6BKjNeu1x3PskDxunl6DO"></a>Section&#160;9, and denominated in a number of shares of Common Stock specified in an Award Agreement.</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ff)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Subsidiary</u></font>&#8221; means any corporation (other than the Company) in an unbroken chain of corporations
      beginning with the Company, provided each corporation (other than the last corporation) in the unbroken chain owns, at the time of the determination, stock possessing 50% or more of the total combined voting power of all classes of stock in one of
      the other corporations in such chain</font></div>
  <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman'; font-size: 10pt;"><a name="z_Toc64352018"></a><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Section 3.&#160; &#160; &#160; Administration</font><font style="font-size: 10pt; font-family: 'Times New Roman';">.</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Committee</u></font>.&#160; The Plan shall be administered and interpreted by the Committee; <font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">provided, however</font>, that any Awards to members of the Board must be authorized by a majority of the Board.&#160; The Committee may delegate authority to one or more subcommittees of the
      Committee, as it deems appropriate.&#160; Subject to compliance with applicable law and the applicable stock exchange rules, the Board, in its discretion, may perform any action of the Committee hereunder.</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Committee Authority</u></font>.&#160; The Committee shall have the sole authority to (i)&#160;determine the individuals to whom Awards
      shall be made under the Plan; (ii)&#160;determine the type, size, terms and conditions of the Awards to be made to each such individual; (iii)&#160;determine the time when the Awards will be made and the duration of any applicable exercise or <a name="z_9kMHG5YVt4666FJdMuAA0my517jV4973"></a>restriction period, including the criteria for exercisability and the acceleration of exercisability, which criteria may be based on the attainment of Performance Goals; (iv) determine the amounts
      payable based on attainment of Performance Goals, including discretion to make such adjustments (positive or negative) to the amounts payable as the Committee deems appropriate and in the best interests of the Company; (v)&#160;amend the terms of any
      previously issued Award, subject to the provisions of <a name="z_9kMHG5YVtCIA6CEcNeu1x3HQaMxzzz13J726njE"></a>Section&#160;18 below; (vi)&#160;determine and adopt terms, guidelines, and provisions, not inconsistent with the Plan and applicable law, that apply
      to individuals residing outside of the United States who receive Awards under the Plan; and (vii)&#160;deal with any other matters arising under the Plan.</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Committee Determinations</u></font>.&#160; The Committee shall have full power and express discretionary authority to administer and
      interpret the Plan, to make factual determinations and to adopt or amend such rules, regulations, agreements and instruments for implementing the Plan and for the conduct of its business as it deems necessary or advisable, in its sole discretion.&#160;
      The Committee&#8217;s written interpretations of the Plan and all determinations made by the Committee pursuant to the powers vested in it hereunder shall be conclusive and binding on all <a name="z_9kMJI5YVt4666GKbKt862"></a>persons having any interest
      in the Plan or in any Awards granted hereunder.&#160; The Committee may rely on internal or external advisors in determining appropriate interpretations of the Plan or Awards granted hereunder.&#160; All powers of the Committee shall be executed in its sole
      discretion, in the best interest of the Company, not as a fiduciary, and in keeping with the objectives of the Plan and need not be uniform as to similarly situated individuals.</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(d)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Indemnification</u></font>.&#160; No member of the Committee or the Board, and no <a name="z_9kMNM5YVt4666ENVHzzzD4l"></a>employee
      of the Company or any Affiliate shall be liable for any act or failure to act with respect to the Plan, except in circumstances involving such person&#8217;s bad faith or willful misconduct, or for any act or failure to act hereunder by any other member of
      the Committee or <a name="z_9kMON5YVt4666ENVHzzzD4l"></a>employee or by any agent to whom duties in connection with the administration of this Plan have been delegated.&#160; The Company shall indemnify members of the Committee and the Board and any
      agent of the Committee or the Board who is an <a name="z_9kMPO5YVt4666ENVHzzzD4l"></a>employee of the Company or a Subsidiary against any and all liabilities or expenses to which they may be subjected by reason of any act or failure to act with
      respect to their duties on behalf of the Plan, except in circumstances involving such <a name="z_9kMKJ5YVt4666GKbKt862"></a>person&#8217;s bad faith or willful misconduct.</font></div>
  <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: normal; font-style: normal;">6</font></div>
    <div class="BRPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div style="text-align: left; margin-bottom: 8pt;"><a name="z_Toc64352019"></a><br>
  </div>
  <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman'; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Section 4.&#160; &#160; &#160; Awards</font><font style="font-size: 10pt; font-family: 'Times New Roman';">.</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>General</u></font>.&#160; Awards under the Plan may consist of Options as described in <a name="z_9kMHG5YVtCIA68HjNeu1x3NmcE84AF"></a>Section&#160;7,
      Stock Awards as described in <a name="z_9kMIH5YVtCIA6BDcNeu1x3OrkDxuTa7379"></a>Section&#160;8, Stock Units as described in <a name="z_9kMIH5YVtCIA6BKjNeu1x3PskDxunl6DO"></a>Section&#160;9, SARs as described in <a name="z_9kMIH5YVtCIA6ABbNeu1x3HIklEyvUUGJ9v0zBK"></a>Section&#160;10, and Other Stock-Based Awards as described in Section&#160;11.&#160; All Awards shall be subject to the terms and conditions set forth herein and to such other terms and conditions consistent
      with this Plan as the Committee deems appropriate and as are specified in writing by the Committee to the individual in the Award Agreement.&#160; All Awards shall be made conditional upon the Participant&#8217;s acknowledgement, in writing or by acceptance of
      the Award, that all decisions and determinations of the Committee shall be final and binding on the Participant, the Participant&#8217;s beneficiaries and any other person having or claiming an interest under such Award.&#160; Awards under a particular
      Section&#160;of the Plan need not be uniform as among the Participants.<a name="z_9kR3WTrAG84AHfLcszv1IvIJ89sp006404VVKL4"></a><a name="z_9kR3WTrAG84BDaLcszv1IvIJ89sp006404VVKL4"></a></font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Minimum Vesting</u></font>.&#160; Awards granted under the Plan shall include regular vesting schedules that provide that no portion
      of an Award shall vest earlier than one year from the date of grant.&#160; However, (i)&#160;for purposes of Awards granted to&#160;Non-Employee&#160;Directors, such Awards shall be deemed to satisfy this minimum vesting requirement if such Awards are granted on the
      date of the Company&#8217;s annual meeting of stockholders and vest on the date of the Company&#8217;s annual meeting of stockholders immediately following the date of grant (but not less than 50 weeks following the date of grant), and (ii)&#160;subject to
      adjustments made in accordance with Section&#160;5(e) below, up to 5% of the shares of Common Stock authorized under the Plan as set forth in Section&#160;5(a) as of the Effective Date may be granted without regard to this minimum vesting requirement.</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Dividends and Dividend Equivalents</u></font>.&#160; Notwithstanding anything to the contrary herein, any dividends or Dividend
      Equivalents granted in connection with Awards under the Plan shall vest and be paid only if and to the extent the underlying Awards vest and are paid.</font></div>
  <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman'; font-size: 10pt;"><a name="z_Toc64352020"></a><font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">Section 5.&#160; &#160; &#160; Shares Subject to the Plan</font>.</div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><a name="z_9kR3WTrAG84AEcLcszv1JuVXmx24bYOC8JENKz"></a><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Shares Authorized</u></font>.&#160; Subject to adjustment as described below in <a name="z_9kMHG5YVtCIA6CHfNeu1x3LxYgFJ2q35khw7CE3"></a>Sections 5(b) and <a name="z_9kMIH5YVtCIA6CFdNeu1x3L0JDtBLLG24KQ"></a>5(e) below, the aggregate number of shares of Common Stock that may be issued or transferred under the Plan shall not exceed
      1,450,000 shares of Common Stock.&#160; In addition, subject to adjustment as described below in Sections 5(b) and 5(e) below, shares of the Common Stock underlying any outstanding award granted under the Prior Plan that, following the Effective Date,
      expires, or is terminated, surrendered, cancelled, or forfeited or exchanged for any reason without issuance of such shares shall be available for new Awards under this Plan.&#160; Subject to adjustment as described below in <a name="z_9kMIH5YVtCIA6CHfNeu1x3LxYgFJ2q35khw7CE3"></a>Sections 5(b) and <a name="z_9kMJI5YVtCIA6CFdNeu1x3L0JDtBLLG24KQ"></a>5(e) below, t<font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">he aggregate number of shares of
        Common Stock that may be issued or transferred under the Plan pursuant to Incentive Stock Options shall not exceed </font>1,450,000 shares of Common Stock<font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">.</font></font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><a name="z_9kR3WTrAG84AFdLcszv1JvWeDH0o13ifu5AC1l0"></a><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Source of Shares; Share Counting</u></font>.&#160; Shares issued or transferred
      under the Plan may be authorized but unissued shares of Common Stock or reacquired shares of Common Stock, including shares purchased by the Company on the open market for purposes of the Plan. If and to the extent Awards granted under the Plan
      expire, terminate or are surrendered cancelled, forfeited, exchanged or without having been exercised, vested or paid in shares, the shares subject to such Awards shall again be available for purposes of the Plan.&#160; Shares of Common Stock surrendered
      in payment of the Exercise Price of an Option (or an option granted under the Prior Plan) shall not be available for&#160;re-issuance&#160;under the Plan. Shares of Common Stock withheld or surrendered for payment of taxes with respect to Awards (or awards
      granted under the Prior Plan) shall not be available for&#160;re-issuance&#160;under the Plan.&#160; If SARs are granted, the full number of shares subject to the SARs shall be considered issued under the Plan, without regard to the number of shares issued upon
      exercise of the SARs. To the extent any Awards are paid in cash, and not in shares of Common Stock, any shares previously subject to such Awards shall again be available for issuance or transfer under the Plan.&#160; For the avoidance of doubt, if shares
      are repurchased by the Company on the open market with the proceeds of the Exercise Price of</font></div>
  <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: normal; font-style: normal;">7</font></div>
    <div class="BRPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div style="margin-bottom: 8pt;"><br>
  </div>
  <div style="text-align: left; margin-bottom: 12pt; font-family: 'Times New Roman'; font-size: 10pt;">Options (including options granted under the Prior Plan), such shares may not again be made available for issuance under the Plan.</div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><a name="z_9kR3WTrAG848DdLcszv1JwXk0zI9ANO9ReB7BD"></a><a name="z_Ref_ContractCompanion_9kb9Ur018"></a><a name="z_Ref_ContractCompanion_9kb9Ur01A"></a><a name="z_Ref_ContractCompanion_9kb9Ur02C"></a><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Substitute Awards</u></font>.&#160; Shares issued or transferred under Awards made pursuant to an assumption, substitution or exchange for previously
      granted awards of a <a name="z_9kMLK5YVt4666GIMHy0poD"></a>company acquired by the Company in a transaction (&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Substitute Awards</u></font>&#8221;) shall not reduce the
      number of shares of Common Stock available under the Plan and available shares under a stockholder approved <a name="z_9kMJI5YVt4666GNeRjm"></a>plan of an acquired <a name="z_9kMML5YVt4666GIMHy0poD"></a>company (as appropriately adjusted to reflect
      the transaction) may be used for Awards under the Plan and shall not reduce the Plan&#8217;s share reserve (subject to applicable stock exchange listing and Code requirements).</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(d)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Individual Limits for Non-Employee Directors</u></font>.&#160; Subject to adjustment as described below in <a name="z_9kMKJ5YVtCIA6CFdNeu1x3L0JDtBLLG24KQ"></a>Section&#160;5(e), the maximum aggregate <a name="z_9kMNM5YVt4666FLUOpm6"></a>grant date value of shares of Common Stock subject to Awards granted to any Non-Employee Director during any calendar year,
      taken together with any cash fees earned by such Non-Employee Director for services rendered as a Non-Employee Director during the calendar year, shall not exceed $750,000 in total value.<font style="font-size: 10pt; font-family: 'Times New Roman'; color: #000000;">&#160;</font> For purposes of this limit, the value of such Awards shall be calculated based on the <a name="z_9kMON5YVt4666FLUOpm6"></a>grant date fair value of such Awards for financial reporting purposes and excluding the value of
      any Dividend Equivalents paid pursuant to any Award granted in a previous year.</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><a name="z_9kR3WTrAG84ADbLcszv1JyHBr9JJE02IO"></a><font style="font-size: 10pt; font-family: 'Times New Roman';">(e)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Adjustments</u></font>.&#160; If there is any change in the number or kind of shares of
      Common Stock outstanding by reason of (i) a stock dividend, spinoff, recapitalization, stock split, reverse stock split or combination or exchange of shares, (ii) a merger, reorganization or consolidation, (iii) a reclassification or change in par
      value, or (iv) any other extraordinary or unusual event affecting the outstanding Common Stock as a class without the Company&#8217;s receipt of consideration, or if the value of outstanding shares of Common Stock is substantially reduced as a result of a
      spinoff or the Company&#8217;s payment of an extraordinary dividend or distribution, the maximum number and kind of shares of Common Stock available for issuance under the Plan, the number and kind of shares covered by outstanding Awards, the number and
      kind of shares issued and to be issued under the Plan, and the price per share or the applicable market value of such Awards shall be equitably adjusted by the Committee to reflect any increase or decrease in the number of, or change in the kind or
      value of, the issued shares of Common Stock to preclude, to the extent practicable, the enlargement or dilution of rights and benefits under the Plan and such outstanding Awards; <font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">provided, however</font>, that any fractional shares resulting from such adjustment shall be eliminated.&#160; In addition, the Committee is authorized to make adjustments in the terms and conditions of, and the criteria included
      in, Awards in recognition of unusual or nonrecurring events (including, without limitation, events described in the preceding sentence, and acquisitions and dispositions of businesses and assets) affecting the Company, any Subsidiary or any business
      unit, or the financial statements of the Company or any Subsidiary, or in response to changes in applicable laws, regulations, or accounting principles.&#160; In addition, in the event of a Change in Control, the provisions of <a name="z_9kMHG5YVtCIA6DEbNeu1x3HLXQ8D54LA43vCNBy"></a>Section&#160;13 of the Plan shall apply.&#160; Any adjustments to outstanding Awards shall be consistent with Section 409A or 424 of the Code, to the extent applicable.&#160; Subject to <a name="z_9kMHG5YVtCIA6CIgNeu1x3HQ1UcnY3HBxyA9BBm"></a>Section&#160;18(b), the adjustments of Awards under this <a name="z_9kMLK5YVtCIA6CFdNeu1x3L0JDtBLLG24KQ"></a>Section&#160;5(e) shall include adjustment of shares, Exercise Price of Options, base amount of
      SARs, Performance Goals or other terms and conditions, as the Committee deems appropriate.&#160; The Committee shall have the sole discretion and authority to determine what appropriate adjustments shall be made and any adjustments determined by the
      Committee shall be final, binding and conclusive.</font></div>
  <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;"><a name="z_Toc64352021"></a><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 6.&#160; &#160; &#160; </font>Eligibility
    for Participation.</div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Eligible Persons</u></font>.&#160; All Employees and Non-Employee Directors shall be eligible to participate in the Plan.&#160; Key
      Advisors shall be eligible to participate in the Plan if the Key Advisors render bona fide services to the Employer, the services are not in connection with the offer and sale of securities in a capital-raising transaction and the Key Advisors do not
      directly or indirectly promote or maintain a market for the Company&#8217;s securities.</font></div>
  <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: normal; font-style: normal;">8</font></div>
    <div class="BRPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div style="margin-bottom: 8pt;"><br>
  </div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Selection of Participants</u></font>.&#160; The Committee shall select the Employees, Non-Employee Directors and Key Advisors to
      receive Awards and shall determine the number of shares of Common Stock subject to a particular Award in such manner as the Committee determines.</font></div>
  <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;"><a name="z_Toc64352022"></a><a name="z_Ref_ContractCompanion_9kb9Ur023"></a><a name="z_Ref_ContractCompanion_9kb9Ur025"></a><a name="z_Ref_ContractCompanion_9kb9Ur027"></a><a name="z_9kR3WTrAG846FhLcszv1LkaC628D"></a><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 7.&#160; &#160; &#160; Options.</font></div>
  <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman'; font-size: 10pt;">The Committee may <a name="z_9kMPO5YVt4666FLUOpm6"></a>grant Options to an Employee, Non-Employee Director or Key Advisor upon such
    terms as the Committee deems appropriate.&#160; The following provisions are applicable to Options:</div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Number of Shares</u></font>.&#160; The Committee shall determine the number of shares of Common Stock that will be subject to each
      Award of Options to Employees, Non-Employee Directors and Key Advisors.</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Type of Option and Exercise Price</u></font>.</font></div>
  <div style="text-align: left; text-indent: 108pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(i)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';">The Committee may <a name="z_9kMHzG6ZWu5777GMVPqn7"></a>grant Incentive Stock Options or Nonqualified Stock Options or any combination of the two, all in accordance with the terms and
      conditions set forth herein.&#160; Incentive Stock Options may be granted only to <a name="z_9kMHzG6ZWu5777FOWI000E5m"></a>employees of the Company or any of its parent or subsidiary corporations, as defined in Section 424 of the Code.&#160; Nonqualified
      Stock Options may be granted to Employees, Non&#8209;Employee Directors and Key Advisors.</font></div>
  <div style="text-align: left; text-indent: 108pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ii)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';">The Exercise Price of Common Stock subject to an Option shall be determined by the Committee and shall be equal to or greater than the Fair Market Value of a share of Common Stock on the date
      the Option is granted.&#160; However, an Incentive Stock Option may not be granted to an Employee who, at the time of <a name="z_9kMH0H6ZWu5777GMVPqn7"></a>grant, owns stock possessing more than 10% of the total combined voting power of all classes of
      stock of the Company, or any parent or subsidiary corporation of the Company, as defined in Section 424 of the Code, unless the Exercise Price per share is not less than 110% of the Fair Market Value of a share of Common Stock on the date of <a name="z_9kMH1I6ZWu5777GMVPqn7"></a>grant.</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Option Term</u></font>.&#160; The Committee shall determine the term of each Option.&#160; The term of any Option shall not exceed ten
      years from the date of <a name="z_9kMH2J6ZWu5777GMVPqn7"></a>grant.&#160; However, an Incentive Stock Option that is granted to an Employee who, at the time of <a name="z_9kMH3K6ZWu5777GMVPqn7"></a>grant, owns stock possessing more than 10% of the total
      combined voting power of all classes of stock of the Company, or any parent or subsidiary corporation of the Company, as defined in Section 424 of the Code, may not have a term that exceeds five years from the date of <a name="z_9kMH4L6ZWu5777GMVPqn7"></a>grant.&#160; Notwithstanding the foregoing, in the event that on the last business day of the term of an Option (other than an Incentive Stock Option), the exercise of the Option is prohibited by applicable law,
      including a prohibition on purchases or sales of Common Stock under the Company&#8217;s insider trading policy, the term of the Option shall be extended for a period of 30 days following the end of the legal prohibition, subject to compliance with Section
      409A or Section 422 of the Code, as applicable, unless the Committee determines otherwise.</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(d)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Exercisability of Options</u></font>.&#160; Subject to Section 4(b), Options shall become exercisable in accordance with such terms
      and conditions, consistent with the Plan, as may be determined by the Committee and specified in the Award Agreement, including upon the attainment of specified Performance Goals.&#160; The Committee may accelerate the exercisability of any or all
      outstanding Options at any time for any reason.</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(e)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Awards to Non-Exempt Employees</u></font>.&#160; Notwithstanding the foregoing, Options granted to <a name="z_9kMLK5YVt4666GKbKt862"></a>persons who are non&#8209;exempt <a name="z_9kMH0H6ZWu5777FOWI000E5m"></a>employees under the Fair Labor Standards Act of 1938, as amended, may not be exercisable for at least six months after the date of <a name="z_9kMH5M6ZWu5777GMVPqn7"></a>grant (except that such Options may become exercisable, as determined by the Committee, upon the Participant&#8217;s death, Disability or retirement, or upon a Change in Control or other circumstances permitted by
      applicable regulations).</font></div>
  <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: normal; font-style: normal;">9</font></div>
    <div class="BRPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div style="margin-bottom: 8pt;"><br>
  </div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(f)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Termination of Employment or Service</u></font>.&#160; Except as provided in the Award Agreement, an Option may only be exercised
      while the Participant is employed by, or providing services to, the Employer.&#160; The Committee shall determine in the Award Agreement under what circumstances and during what time periods a Participant may exercise an Option after termination of
      employment or service.</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(g)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Exercise of Options</u></font>.&#160; A Participant may exercise an Option that has become exercisable, in whole or in part, by
      delivering a notice of exercise to the Company.&#160; The Participant shall pay the Exercise Price for an Option as specified by the Committee (i) in cash or by check, (ii) unless the Committee determines otherwise, by delivering shares of Common Stock
      owned by the Participant and having a Fair Market Value on the date of exercise at least equal to the Exercise Price or by attestation (on a form prescribed by the Committee) to ownership of shares of Common Stock having a Fair Market Value on the
      date of exercise at least equal to the Exercise Price, (iii) by payment through a broker in accordance with procedures permitted by Regulation T of the Federal Reserve Board, (iv) if permitted by the Committee, by withholding shares of Common Stock
      subject to the exercisable Option, which have a Fair Market Value on the date of exercise equal to the Exercise Price, or (v) by such other method as the Committee may approve.&#160; Shares of Common Stock used to exercise an Option shall have been held
      by the Participant for the requisite period of time necessary to avoid adverse accounting consequences to the Company with respect to the Option.&#160; Payment for the shares to be issued or transferred pursuant to the Option, and any required withholding
      taxes, must be received by the Company by the time specified by the Committee depending on the type of payment being made, but in all cases prior to the issuance or transfer of such shares.</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(h)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Limits on Incentive Stock Options</u></font>.&#160; Each Incentive Stock Option shall provide that, if the aggregate Fair Market
      Value of the Common Stock on the date of the <a name="z_9kMH6N6ZWu5777GMVPqn7"></a>grant with respect to which Incentive Stock Options are exercisable for the first time by a Participant during any calendar year, under the Plan or any other stock <a name="z_9kMIH5YVt4666GPfU60w2"></a>option <a name="z_9kMKJ5YVt4666GNeRjm"></a>plan of the Company or a parent or subsidiary, exceeds $100,000, then the Option, as to the excess, shall be treated as a Nonqualified Stock Option.</font></div>
  <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;"><a name="z_Toc64352024"></a><a name="z_Ref_ContractCompanion_9kb9Ur04A"></a><a name="z_Ref_ContractCompanion_9kb9Ur04C"></a><a name="z_Ref_ContractCompanion_9kb9Ur04E"></a><a name="z_9kR3WTrAG849BaLcszv1MpiBvsRY5157"></a><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 8.&#160; &#160; &#160; Stock Awards.</font></div>
  <div style="text-align: left; text-indent: 36pt; margin-bottom: 6pt; font-family: 'Times New Roman'; font-size: 10pt;">The Committee may issue or transfer shares of Common Stock to an Employee, Non&#8209;Employee Director or Key Advisor under a Stock Award,
    upon such terms as the Committee deems appropriate.&#160; The following provisions are applicable to Stock Awards:</div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><a name="z_9kR3WTrAG847HiLcszv1MxJIwx2zuma6NGEB78A"></a><a name="z_Ref_ContractCompanion_9kb9Ur03B"></a><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>General Requirements</u></font>.&#160;
      Shares of Common Stock issued or transferred pursuant to Stock Awards may be issued or transferred for consideration or for no consideration, and subject to restrictions or no restrictions, as determined by the Committee.&#160; Subject to Section&#160;4(b),
      the Committee may, but shall not be required to, establish conditions under which restrictions on Stock Awards shall lapse over a period of time or according to such other criteria as the Committee deems appropriate, including, without limitation,
      restrictions based on the achievement of specific Performance Goals.&#160; The period of time during which the Stock Awards will remain subject to restrictions will be designated in the Award Agreement as the &#8220;<a name="z_9kMHG5YVt3BC6EKfMuAA0my517jV4973"></a><a name="z_9kR3WTr2444DHbKs88ykw3z5hT2751"></a><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Restriction Period</u></font>.&#8221;</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Number of Shares</u></font>.&#160; The Committee shall determine the number of shares of Common Stock to be issued or transferred
      pursuant to a Stock Award and the restrictions applicable to such shares.</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Requirement of Employment or Service</u></font>.&#160; If the Participant ceases to be employed by, or provide service to, the
      Employer during a period designated in the Award Agreement as the Restriction Period, or if other specified conditions are not met, the Stock Award shall terminate as to all shares covered by the Award as to which the restrictions have not lapsed,
      and those shares of Common Stock must be immediately returned to the Company.&#160; The Committee may, however, provide for complete or partial exceptions to this requirement as it deems appropriate.</font></div>
  <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: normal; font-style: normal;">10</font></div>
    <div class="BRPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div style="margin-bottom: 8pt;"><br>
  </div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(d)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Restrictions on Transfer and Legend on Stock Certificate</u></font>.&#160; During the Restriction Period, a Participant may not
      sell, assign, transfer, pledge or otherwise dispose of the shares of a Stock Award except under <a name="z_9kMHG5YVtCIA6CKiNeu1x3HOrkyvE7u74py9AJa"></a>Section&#160;16 below.&#160; Unless otherwise determined by the Committee, the Company will retain
      possession of certificates for shares of Stock Awards until all restrictions on such shares have lapsed.&#160; Each certificate for a Stock Award, unless held by the Company, shall contain a legend giving appropriate notice of the restrictions in the
      Award.&#160; The Participant shall be entitled to have the legend removed from the stock certificate covering the shares subject to restrictions when all restrictions on such shares have lapsed.&#160; The Committee may determine that the Company will not issue
      certificates for Stock Awards until all restrictions on such shares have lapsed.</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(e)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Right to Vote and to Receive Dividends</u></font>.&#160; Unless the Committee determines otherwise, during the Restriction Period,
      the Participant shall have the right: (i)&#160;to vote shares of Stock Awards and (ii)&#160;subject to Section 4(c), to receive any dividends or other distributions paid on such shares, subject to any restrictions deemed appropriate by the Committee,
      including, without limitation, the achievement of specific Performance Goals.</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(f)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Lapse of Restrictions</u></font>.&#160; All restrictions imposed on Stock Awards shall lapse upon the expiration of the applicable
      Restriction Period and the satisfaction of all conditions, if any, imposed by the Committee.&#160; The Committee may determine, as to any or all Stock Awards, that the restrictions shall lapse without regard to any Restriction Period.</font></div>
  <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;"><a name="z_Toc64352025"></a><a name="z_Ref_ContractCompanion_9kb9Ur058"></a><a name="z_Ref_ContractCompanion_9kb9Ur05A"></a><a name="z_Ref_ContractCompanion_9kb9Ur05C"></a><a name="z_9kR3WTrAG849IhLcszv1NqiBvslj4BM"></a><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 9.&#160; &#160; &#160; Stock Units.</font></div>
  <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman'; font-size: 10pt;">The Committee may <a name="z_9kMH7O6ZWu5777GMVPqn7"></a>grant Stock Units, each of which shall represent one hypothetical share of
    Common Stock, to an Employee, Non-Employee Director or Key Advisor upon such terms and conditions as the Committee deems appropriate.&#160; The following provisions are applicable to Stock Units:</div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Crediting of Units</u></font>.&#160; Each Stock Unit shall represent the right of the Participant to receive a share of Common Stock
      or an amount of cash based on the value of a share of Common Stock, if and when specified conditions are met.&#160; All Stock Units shall be credited to bookkeeping accounts established on the Company&#8217;s records for purposes of the Plan.</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Terms of Stock Units</u></font>.&#160; Subject to Section 4(b), the Committee may <a name="z_9kMH8P6ZWu5777GMVPqn7"></a>grant Stock
      Units that vest and are payable if specified Performance Goals or other conditions are met, or under other circumstances.&#160; Stock Units may be paid at the end of a specified performance period or other period, or payment may be deferred to a date
      authorized by the Committee.&#160; The Committee may accelerate vesting or payment, as to any or all Stock Units at any time for any reason, provided such acceleration complies with Section 409A of the Code.&#160; The Committee shall determine the number of
      Stock Units to be granted and the requirements applicable to such Stock Units.</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Requirement of Employment or Service</u></font>.&#160; If the Participant ceases to be employed by, or provide service to, the
      Employer prior to the vesting of Stock Units, or if other conditions established by the Committee are not met, the Participant&#8217;s Stock Units shall be forfeited.&#160; The Committee may, however, provide for complete or partial exceptions to this
      requirement as it deems appropriate.</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(d)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Payment With Respect to Stock Units</u></font>.&#160; Payments with respect to Stock Units shall be made in cash, Common Stock or
      any combination of the foregoing, as the Committee shall determine.</font></div>
  <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;"><a name="z_Toc64352026"></a><a name="z_Ref_ContractCompanion_9kb9Ur035"></a><a name="z_Ref_ContractCompanion_9kb9Ur037"></a><a name="z_Ref_ContractCompanion_9kb9Ur039"></a><a name="z_9kR3WTrAG8489ZLcszv1FGijCwtSSEH7tyx9IEK"></a><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 10.&#160; &#160; &#160; </font>Stock
    Appreciation Rights.</div>
  <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman'; font-size: 10pt;">The Committee may <a name="z_9kMI0G6ZWu5777GMVPqn7"></a>grant SARs to an Employee, Non&#8209;Employee Director or Key Advisor separately or
    in tandem with any Option.&#160; The following provisions are applicable to SARs:</div>
  <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: normal; font-style: normal;">11</font></div>
    <div class="BRPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div style="margin-bottom: 8pt;"><br>
  </div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>General Requirements</u></font>.&#160; The Committee may <a name="z_9kMI1H6ZWu5777GMVPqn7"></a>grant SARs to an Employee,
      Non&#8209;Employee Director or Key Advisor separately or in tandem with any Option (for all or a portion of the applicable Option).&#160; Tandem SARs may be granted either at the time the Option is granted or at any time thereafter while the Option remains
      outstanding; <font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">provided, however</font>, that, in the case of an Incentive Stock Option, SARs may be granted only at the time of the <a name="z_9kMI2I6ZWu5777GMVPqn7"></a>grant
      of the Incentive Stock Option.&#160; The Committee shall establish the base amount of the SAR at the time the SAR is granted.&#160; The base amount of each SAR shall be equal to or greater than the Fair Market Value of a share of Common Stock as of the date of
      <a name="z_9kMI3J6ZWu5777GMVPqn7"></a>grant of the SAR.&#160; The term of any SAR shall not exceed ten years from the date of <a name="z_9kMI4K6ZWu5777GMVPqn7"></a>grant.&#160; Notwithstanding the foregoing, in the event that on the last business day of the
      term of a SAR, the exercise of the SAR is prohibited by applicable law, including a prohibition on purchases or sales of Common Stock under the Company&#8217;s insider trading policy, the term shall be extended for a period of 30 days following the end of
      the legal prohibition, unless the Committee determines otherwise, consistent with Section 409A of the Code.</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Tandem SARs</u></font>.&#160; In the case of tandem SARs, the number of SARs granted to a Participant that shall be exercisable
      during a specified period shall not exceed the number of shares of Common Stock that the Participant may purchase upon the exercise of the related Option during such period.&#160; Upon the exercise of an Option, the SARs relating to the Common Stock
      covered by such Option shall terminate.&#160; Upon the exercise of SARs, the related Option shall terminate to the extent of an equal number of shares of Common Stock.</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Exercisability</u></font>.&#160; Subject to Section 4(b), a SAR shall be exercisable during the period specified by the Committee in
      the Award Agreement and shall be subject to such vesting and other restrictions as may be specified in the Award Agreement, including the attainment of specified Performance Goals.&#160; The Committee may accelerate the exercisability of any or all
      outstanding SARs at any time for any reason.&#160; SARs may only be exercised while the Participant is employed by, or providing service to, the Employer or during the applicable period after termination of employment or service as specified by the
      Committee.&#160; A tandem SAR shall be exercisable only during the period when the Option to which it is related is also exercisable.</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(d)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Awards to Non&#8209;Exempt Employees</u></font>.&#160; Notwithstanding the foregoing, SARs granted to <a name="z_9kMML5YVt4666GKbKt862"></a>persons
      who are non&#8209;exempt <a name="z_9kMH1I6ZWu5777FOWI000E5m"></a>employees under the Fair Labor Standards Act of 1938, as amended, may not be exercisable for at least six months after the date of <a name="z_9kMI5L6ZWu5777GMVPqn7"></a>grant (except that
      such SARs may become exercisable, as determined by the Committee, upon the Participant&#8217;s death, Disability or retirement, or upon a Change in Control or other circumstances permitted by applicable regulations).</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(e)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Value of SARs</u></font>.&#160; When a Participant exercises SARs, the Participant shall receive in settlement of such SARs an
      amount equal to the value of the stock appreciation for the number of SARs exercised.&#160; The stock appreciation for a SAR is the amount by which the Fair Market Value of the underlying Common Stock on the date of exercise of the SAR exceeds the base
      amount of the SAR as described in Section&#160;10(a).</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(f)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Form of Payment</u></font>.&#160; The appreciation in a SAR shall be paid in shares of Common Stock, cash or any combination of the
      foregoing, as the Committee shall determine.&#160; For purposes of calculating the number of shares of Common Stock to be received, shares of Common Stock shall be valued at their Fair Market Value on the<a name="z_Toc64352027"></a> date of exercise of
      the SAR.</font></div>
  <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;"><a name="z_Ref_ContractCompanion_9kb9Ur029"></a><a name="z_Ref_ContractCompanion_9kb9Ur046"></a><a name="z_9kR3WTrAG848CcLcszv1FHff5r2roH1yYJ7CyVj"></a><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 11.&#160; &#160; &#160; </font>Other Stock-Based Awards.</div>
  <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman'; font-size: 10pt;">The Committee may <a name="z_9kMI6M6ZWu5777GMVPqn7"></a>grant Other Stock-Based Awards, which are awards (other than those described
    in <a name="z_9kMIH5YVtCIA68HjNeu1x3NmcE84AF"></a>Sections 7, <a name="z_9kMJI5YVtCIA6BDcNeu1x3OrkDxuTa7379"></a>8, <a name="z_9kMJI5YVtCIA6BKjNeu1x3PskDxunl6DO"></a>9 and <a name="z_9kMJI5YVtCIA6ABbNeu1x3HIklEyvUUGJ9v0zBK"></a>10 of the Plan) that
    are based on or measured by Common Stock, to any Employee, Non-Employee Director or Key Advisor, on such terms and conditions as the Committee shall determine.&#160; Subject to Section 4(b), Other Stock-Based Awards may be awarded subject to the</div>
  <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: normal; font-style: normal;">12</font></div>
    <div class="BRPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div style="margin-bottom: 8pt;"><br>
  </div>
  <div style="text-align: left; margin-bottom: 12pt; font-family: 'Times New Roman'; font-size: 10pt;">achievement of Performance Goals or other criteria or other conditions and may be payable in cash, Common Stock or any combination of the foregoing, as
    the Committee shall determine.</div>
  <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;"><a name="z_Toc64352028"></a><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 12.&#160; &#160; &#160; </font>Dividend
    Equivalents.</div>
  <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman'; font-size: 10pt;">The Committee may <a name="z_9kMI7N6ZWu5777GMVPqn7"></a>grant Dividend Equivalents in connection with Stock Units or Other
    Stock-Based Awards in an applicable Award Agreement or at any point following the grant of such Award.&#160; Subject to Section&#160;4(c), Dividend Equivalents may be accrued as contingent cash obligations and may be payable in cash or shares of Common Stock,
    and upon such terms and conditions as the Committee shall determine.&#160; For the avoidance of doubt, dividends or Dividend Equivalents shall not be granted in connection with Options or SARs.</div>
  <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;"><a name="z_Toc64352033"></a><a name="z_Ref_ContractCompanion_9kb9Ur06F"></a><a name="z_9kR3WTrAG84BCZLcszv1FJVO6B32J821tAL9wUW"></a><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 13.&#160; &#160; &#160; </font>Consequences of a Change in Control.</div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Assumption of Outstanding Awards</u></font>.&#160; Upon a Change in Control where the Company is not the surviving corporation (or
      survives only as a subsidiary of another corporation), unless the Committee determines otherwise, all outstanding Awards that are not exercised or paid at the time of the Change in Control shall be assumed by, or replaced with <a name="z_9kMI8O6ZWu5777GMVPqn7"></a>grants (which may be in respect to cash, securities, or a combination thereof) that have comparable terms by, the surviving corporation (or a parent or subsidiary of the surviving corporation).&#160; After a Change in
      Control, references to the &#8220;Company&#8221; as they relate to employment matters shall include the successor <a name="z_9kMHG5YVt4666FHOHzzzD4y"></a>employer in the transaction, subject to applicable law.&#160; For purposes of the foregoing, an Award under the
      Plan shall not be treated as continued, assumed, or replaced on comparable terms unless it is continued, assumed, or replaced with substantially equivalent terms, including, without limitation, the same vesting terms.</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><a name="z_9kR3WTrAG84BEbLcszv1FJuaY2I943lpGFeQCSC"></a><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Vesting Upon Certain Terminations of Employment</u></font>.&#160; Unless the
      Committee determines otherwise or the applicable Award Agreement provides otherwise, if a Participant&#8217;s employment or services terminate by reason of an involuntary termination by the Company other than for Cause upon or within 12 months following a
      Change in Control, the Participant&#8217;s outstanding Awards shall become fully vested as of the date of such termination; <font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">provided</font> that if the vesting of any such
      Awards is based, in whole or in part, on performance, the applicable Award Agreement shall specify how the portion of the Award that becomes vested pursuant to this <a name="z_9kMHG5YVtCIA6DGdNeu1x3HLwca4KB65nrIHgSE"></a>Section 13(b) shall be
      calculated.</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Other Alternatives</u></font>.&#160; In the event of a Change in Control, if any outstanding Awards are not assumed by, or replaced
      with <a name="z_9kMI9P6ZWu5777GMVPqn7"></a>grants that have comparable terms by, the surviving corporation (or a parent or subsidiary of the surviving corporation), the Committee may (but is not obligated to) make adjustments to the terms and
      conditions of outstanding Awards, including, without limitation, taking any of the following actions (or combination thereof) with respect to any or all outstanding Awards, without the consent of any Participant: (i)&#160;the Committee may determine that
      outstanding Options and SARs shall automatically accelerate and become fully exercisable and the restrictions and conditions on outstanding Stock Awards, Stock Units, Other Stock-Based Awards and Dividend Equivalents shall immediately lapse; (ii)&#160;the
      Committee may determine that Participants shall receive a payment in settlement of outstanding Stock Units, Other Stock-Based Awards or Dividend Equivalents, in such amount and form as may be determined by the Committee; (iii)&#160;the Committee may
      require that Participants surrender their outstanding Options and SARs in exchange for a payment by the Company, in cash or Common Stock as determined by the Committee, in an amount equal to the amount, if any, by which the then Fair Market Value of
      the shares of Common Stock subject to the Participant&#8217;s unexercised Options and SARs exceeds the <a name="z_9kR3WTr2664CJbS4yu0RW3yxp63bj9vs5JyCC"></a>Option Exercise Price or SAR base amount, and (iv)&#160;after giving Participants an opportunity to
      exercise all of their outstanding Options and SARs, the Committee may terminate any or all unexercised Options and SARs at such time as the Committee deems appropriate.&#160; Such surrender, termination or payment shall take place as of the date of the
      Change in Control or such other date as the Committee may specify.&#160; Without limiting the foregoing, if the per share Fair Market Value of the Common Stock does not exceed the per share <a name="z_9kMHG5YVt4886ELdU60w2TY50zr85dlBxu7L0EE"></a>Option
      Exercise Price or SAR base amount, as applicable, the Company shall not be required to make any payment to the Participant upon surrender of the Option or SAR.</font></div>
  <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: normal; font-style: normal;">13</font></div>
    <div class="BRPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div style="text-align: left; margin-bottom: 8pt;"><a name="z_Toc64352030"></a><a name="z_Toc64352034"></a><br>
  </div>
  <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 14.&#160; &#160; &#160; Deferrals.</font></div>
  <div style="text-align: left; text-indent: 36pt; margin-bottom: 6pt; font-family: 'Times New Roman'; font-size: 10pt;">The Committee may permit or require a Participant to defer receipt of the payment of cash or the delivery of shares that would
    otherwise be due to such Participant in connection with any Award.&#160; If any such deferral election is permitted or required, the Committee shall establish rules and procedures for such deferrals and may provide for interest or other earnings to be paid
    on such deferrals.&#160; The rules and procedures for any such deferrals shall be consistent with applicable requirements of Section 409A of the Code.</div>
  <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;"><a name="z_Toc64352031"></a><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 15.&#160; &#160; &#160; </font>Withholding
    of Taxes.</div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Required Withholding</u></font>.&#160; All Awards under the Plan shall be subject to applicable United States federal (including
      FICA), state and local, foreign country or other tax withholding requirements.&#160; The Employer may require that the Participant or other person receiving Awards or exercising Awards pay to the Employer an amount sufficient to satisfy such tax
      withholding requirements with respect to such Awards, or the Employer may deduct from other wages and compensation paid by the Employer the amount of any withholding taxes due with respect to such Awards, or the Employer may take such other action as
      the Committee may deem advisable to enable the Employer to satisfy obligations for the payment of withholding taxes and other tax obligations relating to any Award.</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Share Withholding</u></font>.&#160; The Committee may permit or require the Employer&#8217;s tax withholding obligation with respect to
      Awards paid in Common Stock to be satisfied by having shares withheld up to an amount that does not exceed the Participant&#8217;s applicable withholding tax rate for United States federal (including FICA), state and local, foreign country or other tax
      liabilities.&#160; The Committee may, in its discretion, and subject to such rules as the Committee may adopt, allow Participants to elect to have such share withholding applied to all or a portion of the tax withholding obligation arising in connection
      with any particular Award.&#160; Unless the Committee determines otherwise, share withholding for taxes shall not exceed the Participant&#8217;s minimum applicable tax withholding amount.</font></div>
  <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;"><a name="z_Toc64352032"></a><a name="z_9kR3WTrAG84AIgLcszv1FMpiwtC5s52nw78HYUC"></a><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 16.&#160; &#160; &#160; </font>Transferability of Awards.</div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Nontransferability of Awards</u></font>.&#160; Except as described in <a name="z_9kMHG5YVtCIA6DHeNeu1x3HOzalzwF8v8J8imJM"></a>subsection
      (b) below, only the Participant may exercise rights under an Award during the Participant&#8217;s lifetime.&#160; A Participant may not transfer those rights except (i) by will or by the laws of descent and distribution or (ii) with respect to Awards other than
      Incentive Stock Options, pursuant to a domestic relations order.&#160; When a Participant dies, the personal representative or other person entitled to succeed to the rights of the Participant may exercise such rights.&#160; Any such successor must furnish
      proof satisfactory to the Company of the successor&#8217;s right to receive the Award under the Participant&#8217;s will or under the applicable laws of descent and distribution.</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><a name="z_9kR3WTrAG84BFcLcszv1FMxYjxuD6t6H6gkHKSD"></a><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Transfer of Nonqualified Stock Options and Stock Awards</u></font>.&#160;
      Notwithstanding the foregoing, the Committee may provide, in an Award Agreement or at such other time after the <a name="z_9kMJ1G6ZWu5777GMVPqn7"></a>grant of an award, that a Participant may transfer Nonqualified Stock Options or Stock Awards to
      family members, or one or more trusts or other entities for the benefit of or owned by family members, consistent with the applicable securities laws, according to such terms as the Committee may determine; <font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">provided</font> that the Participant receives no consideration for the transfer of an Option or Stock Award and the transferred Option or Stock Award shall continue to be subject to the same terms and
      conditions as were applicable to the Option or Stock Award immediately before the transfer.</font></div>
  <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;"><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 17.&#160; &#160; &#160; </font>Requirements for Issuance
    or Transfer of Shares</div>
  <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman'; font-size: 10pt;">No Common Stock shall be issued or transferred in connection with any Award hereunder unless and until all legal requirements
    applicable to the issuance or transfer of such Common Stock have been complied with to the satisfaction of the Committee.&#160; The Committee shall have the right to condition any</div>
  <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: normal; font-style: normal;">14</font></div>
    <div class="BRPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div style="margin-bottom: 8pt;"><br>
  </div>
  <div style="text-align: left; margin-bottom: 12pt; font-family: 'Times New Roman'; font-size: 10pt;">Award on the Participant&#8217;s undertaking in writing to comply with such restrictions on the Participant&#8217;s subsequent disposition of the shares of Common
    Stock as the Committee shall deem necessary or advisable, and certificates representing such shares may be legended to reflect any such restrictions.&#160; Certificates representing shares of Common Stock issued or transferred under the Plan may be subject
    to such stop-transfer orders and other restrictions as the Committee deems appropriate to comply with applicable laws, regulations and interpretations, including any requirement that a legend be placed thereon.</div>
  <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;"><a name="z_Toc64352035"></a><a name="z_Ref_ContractCompanion_9kb9Ur05F"></a><a name="z_9kR3WTrAG84ACaLcszv1FOYKvxxxz1H504lhCLD"></a><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 18.&#160; &#160; &#160; </font>Amendment and Termination of the Plan.</div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Amendment</u></font>.&#160; The Board may amend or terminate the Plan at any time; <font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">provided, however</font>, that the Board shall not amend the Plan without stockholder approval if such approval is required in order to comply with the Code or other applicable law, or to comply with
      applicable stock exchange requirements.</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><a name="z_9kR3WTrAG84AGeLcszv1FOzSalW1F9vw8799kpR"></a><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>No Repricing of Options or SARs</u></font>.&#160; Except in connection with a
      corporate transaction involving the Company (including, without limitation, any stock dividend, distribution (whether in the form of cash, Common Stock, other securities or property), stock split, extraordinary cash dividend, recapitalization, change
      in control, reorganization, merger, consolidation, split-up, spin-off, combination, repurchase or exchange of shares of Common Stock or other securities, or similar transactions), the Company may not, without obtaining stockholder approval, (i) amend
      the terms of outstanding Options or SARs to reduce the Exercise Price of such outstanding Options or base price of such SARs, (ii) cancel outstanding Options or SARs in exchange for Options or SARs with an Exercise Price or base price, as applicable,
      that is less than the Exercise Price or base price of the original Options or SARs or (iii) cancel outstanding Options or SARs with an Exercise Price or base price, as applicable, above the current stock price in exchange for cash or other
      securities.</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Termination of Plan</u></font>.&#160; The Plan shall terminate on the day immediately preceding the tenth anniversary of its
      Effective Date, unless the Plan is terminated earlier by the Board or is extended by the Board with the approval of the stockholders.</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(d)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Termination and Amendment of Outstanding Awards</u></font>.&#160; A termination or amendment of the Plan that occurs after an Award
      is made shall not materially impair the rights of a Participant with respect to such Award unless the Participant consents or unless the Committee acts under <a name="z_9kMHG5YVtCIA6DIfNeu1x3HR6NR8AA4u03vGLJJ"></a>Section&#160;19(f) below.&#160; The
      termination of the Plan shall not impair the power and authority of the Committee with respect to an outstanding Award.&#160; Whether or not the Plan has terminated, an outstanding Award may be terminated or amended under <a name="z_9kMIH5YVtCIA6DIfNeu1x3HR6NR8AA4u03vGLJJ"></a>Section&#160;19(f) below or may be amended by agreement of the Company and the Participant consistent with the Plan.</font></div>
  <div style="text-align: left; text-indent: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;"><a name="z_Toc64352036"></a><font style="font-size: 10pt; font-family: 'Times New Roman';">Section 19.&#160; &#160; &#160; Miscellaneous.</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Awards in Connection with Corporate Transactions and Otherwise</u></font>.&#160; Nothing contained in the Plan shall be construed to
      (i) limit the right of the Committee to make Awards under the Plan in connection with the acquisition, by purchase, lease, merger, consolidation or otherwise, of the business or assets of any corporation, firm or association, including Awards to <a name="z_9kMH2J6ZWu5777FOWI000E5m"></a>employees thereof who become Employees, or (ii) limit the right of the Company to <a name="z_9kMJ2H6ZWu5777GMVPqn7"></a>grant stock <a name="z_9kMJI5YVt4666GPfU60w2"></a>options or make other awards outside
      of the Plan.&#160; The Committee may make an Award to an <a name="z_9kMH3K6ZWu5777FOWI000E5m"></a>employee of another corporation who becomes an Employee by reason of a corporate merger, consolidation, acquisition of stock or property, reorganization or
      liquidation involving the Company, in substitution for a stock <a name="z_9kMKJ5YVt4666GPfU60w2"></a>option or <a name="z_9kMIH5YVt4666FOjc5pmLSzvz"></a>stock awards <a name="z_9kMJ3I6ZWu5777GMVPqn7"></a>grant made by such corporation.&#160;
      Notwithstanding anything in the Plan to the contrary, the Committee may establish such terms and conditions of the new Awards as it deems appropriate, including setting the Exercise Price of Options or the base price of SARs at a price necessary to
      retain for the Participant the same economic value as the prior <a name="z_9kMLK5YVt4666GPfU60w2"></a>options or rights.</font></div>
  <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: normal; font-style: normal;">15</font></div>
    <div class="BRPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div style="margin-bottom: 8pt;"><br>
  </div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Governing Document</u></font>.&#160; The Plan shall be the controlling document.&#160; No other statements, representations, explanatory
      materials or examples, oral or written, may amend the Plan in any manner.&#160; The Plan shall be binding upon and enforceable against the Company and its successors and assigns.</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Funding of the Plan</u></font>.&#160; The Plan shall be unfunded.&#160; The Company shall not be required to establish any special or
      separate fund or to make any other segregation of assets to assure the payment of any Awards under the Plan.</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(d)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Rights of Participants</u></font>.&#160; Nothing in the Plan shall entitle any Employee, Non&#8209;Employee Director, Key Advisor or other
      person to any claim or right to receive an Award under the Plan.&#160; Neither the Plan nor any action taken hereunder shall be construed as giving any individual any rights to be retained by or in the employ of the Employer or any other employment
      rights.</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(e)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>No Fractional Shares</u></font>.&#160; No fractional shares of Common Stock shall be issued or delivered pursuant to the Plan or any
      Award.&#160; Except as otherwise provided under the Plan, the Committee shall determine whether cash, other awards or other property shall be issued or paid in lieu of such fractional shares or whether such fractional shares or any rights thereto shall be
      forfeited or otherwise eliminated.</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><a name="z_9kR3WTrAG84BGdLcszv1FP4LP6882sy1tEJHHkY"></a><font style="font-size: 10pt; font-family: 'Times New Roman';">(f)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Compliance with Law</u></font>.</font></div>
  <div style="text-align: left; text-indent: 108pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(i)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';">The Plan, the exercise of Options and SARs and the obligations of the Company to issue or transfer shares of Common Stock under Awards shall be subject to all applicable laws and regulations,
      and to approvals by any governmental or regulatory agency as may be required.&#160; With respect to <a name="z_9kMNM5YVt4666GKbKt862"></a>persons subject to Section 16 of the Exchange Act, it is the intent of the Company that the Plan and all
      transactions under the Plan comply with all applicable provisions of Rule 16b-3 or its successors under the Exchange Act.&#160; In addition, it is the intent of the Company that Incentive Stock Options comply with the applicable provisions of Section 422
      of the Code, and that, to the extent applicable, Awards comply with the requirements of Section 409A of the Code.&#160; To the extent that any legal requirement of Section 16 of the Exchange Act or Section 422 or 409A of the Code as set forth in the Plan
      ceases to be required under Section 16 of the Exchange Act or Section 422 or 409A of the Code, that Plan provision shall cease to apply.&#160; The Committee may revoke any Award if it is contrary to law or modify an Award to bring it into compliance with
      any valid and mandatory government regulation.&#160; The Committee may also adopt rules regarding the withholding of taxes on payments to Participants.&#160; The Committee may, in its sole discretion, agree to limit its authority under this Section.</font></div>
  <div style="text-align: left; text-indent: 108pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ii)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';">The Plan is intended to comply with the requirements of Section&#160;409A of the Code, to the extent applicable.&#160; Each Award shall be construed and administered such that the Award either (A)
      qualifies for an exemption from the requirements of Section 409A of the Code or (B) satisfies the requirements of Section 409A of the Code.&#160; If an Award is subject to Section 409A of the Code, (I) distributions shall only be made in a manner and upon
      an event permitted under Section 409A of the Code, (II) payments to be made upon a termination of employment or service shall only be made upon a &#8220;separation from service&#8221; under Section 409A of the Code, (III) unless the Award specifies otherwise,
      each installment payment shall be treated as a separate payment for purposes of Section 409A of the Code, and (IV) in no event shall a Participant, directly or indirectly, designate the calendar year in which a distribution is made except in
      accordance with Section 409A of the Code.</font></div>
  <div style="text-align: left; text-indent: 108pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(iii)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';">Any Award that is subject to Section 409A of the Code and that is to be distributed to a Key Employee (as defined below) upon separation from service shall be administered so that any
      distribution with respect to such Award shall be postponed for six months following the date of the Participant&#8217;s separation from service, if required by Section 409A of the Code.&#160; If a distribution is delayed pursuant to Section 409A of the Code,
      the distribution shall be paid within 15 days after the end of the six-month period.&#160; If the Participant dies during such six-month period, any postponed amounts</font></div>
  <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: normal; font-style: normal;">16</font></div>
    <div class="BRPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div style="margin-bottom: 8pt;"><br>
  </div>
  <div style="text-align: left; margin-bottom: 12pt; font-family: 'Times New Roman'; font-size: 10pt;">shall be paid within 90 days of the Participant&#8217;s death.&#160; The determination and identification of &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;"><u>Key Employees</u></font>&#8221;, including the number and identity of <a name="z_9kMON5YVt4666GKbKt862"></a>persons considered Key Employees and the identification date, shall be made by the Committee or its delegate each
    year in accordance with Section 416(i) of the Code and the &#8220;specified <a name="z_9kMH4L6ZWu5777FOWI000E5m"></a>employee&#8221; requirements of Section 409A of the Code.</div>
  <div style="text-align: left; text-indent: 108pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(iv)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';">Notwithstanding anything in the Plan or any Award agreement to the contrary, each Participant shall be solely responsible for the tax consequences of Awards under the Plan, and in no event
      shall the Company or any Subsidiary or <a name="z_9kMIH5YVt4666GQS6imtukw1"></a>Affiliate of the Company have any responsibility or liability if an Award does not meet any applicable requirements of Section 409A of the Code.&#160; Although the Company
      intends to administer the Plan to prevent taxation under Section 409A of the Code, the Company does not represent or warrant that the Plan or any Award complies with any provision of federal, state, local or other tax law.</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(g)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Awards in Foreign Countries; Establishment of Subplans</u></font>.&#160; The Committee has the authority to award Awards to
      Participants who are foreign nationals or employed outside the United States on any different terms and conditions than those specified in the Plan that the Committee, in its discretion, believes to be necessary or desirable to accommodate
      differences in applicable law, tax policy, or custom, while furthering the purposes of the Plan. The Board may from time to time establish one or more sub-<a name="z_9kMLK5YVt4666GNeRjm"></a>plans under the Plan for purposes of satisfying applicable
      blue sky, securities or tax laws of various jurisdictions.&#160; The Board shall establish such sub-<a name="z_9kMML5YVt4666GNeRjm"></a>plans by adopting supplements to the Plan setting forth (i) such limitations on the Committee&#8217;s discretion under the
      Plan as the Board deems necessary or desirable and (ii) such additional terms and conditions not otherwise inconsistent with the Plan as the Board shall deem necessary or desirable.&#160; All supplements adopted by the Board shall be deemed to be part of
      the Plan, but each supplement shall apply only to Participants within the affected jurisdiction and the Employer shall not be required to provide copies of any supplement to Participants in any jurisdiction that is not affected.&#160; Notwithstanding the
      foregoing, the Committee may not approve any sub-<a name="z_9kMNM5YVt4666GNeRjm"></a>plan inconsistent with the terms or share limits in the Plan or which would otherwise <a name="z_9kMHG5YVt4666FGL3sBw"></a><a name="z_9kMHG5YVt4666FIN3sBw"></a>cause
      the Plan to cease to satisfy any conditions under Rule 16b-3 under the <a name="z_9kR3WTr2664CKO1r"></a>Exchange Act.</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(h)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Company Policies and Clawback Rights</u></font>.</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-left: 36pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(i)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';">All Awards under the Plan shall be subject to any applicable share trading policies and other policies that may be approved or implemented by the Board or the Committee from time to time,
      whether or not approved before or after the Effective Date.&#160; All Awards and amounts payable under the Plan are additionally subject to the terms of any applicable clawback policies approved by the Board or Committee, as in effect from time to time
      (including, without limitation, a clawback policy required to be implemented by an applicable stock exchange), whether approved before or after the date of grant of an Award (as applicable, a &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold; font-style: italic;">Clawback Policy</font>&#8221;).&#160; Further, to the extent permitted by applicable law, including without limitation Section 409A of the Code, all amounts payable under the Plan are subject to offset in the
      event that a Participant has an outstanding clawback, recoupment or forfeiture obligation to the Company under the terms of any applicable Clawback Policy.&#160; In the event of a clawback, recoupment or forfeiture event under an applicable Clawback
      Policy, the amount required to be clawed back, recouped or forfeited pursuant to such policy shall be deemed not to have been earned under the terms of the Plan, and the Company shall be entitled to recover from the Participant the amount specified
      under the Clawback Policy to be clawed back, recouped or forfeited (which amount, as applicable, shall be deemed an advance that remained subject to the Participant satisfying all eligibility conditions for earning the amounts deferred, accrued, or
      credited under this Plan).</font></div>
  <div style="text-align: left; text-indent: 72pt; margin-left: 36pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(ii)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';">Subject to the requirements of applicable law, the Committee may provide in any Award Agreement that, if a Participant breaches any restrictive covenant obligation or agreement between the
      Participant and the Employer (which may be set forth in any Award Agreement) or otherwise engages in activities that constitute Cause either while employed by, or providing service to, the Employer or within a specified period of time thereafter, all
      Awards held</font></div>
  <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
    <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: normal; font-style: normal;">17</font></div>
    <div class="BRPFPageBreak" style="page-break-after: always;">
      <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
  </div>
  <div style="margin-bottom: 8pt;"><br>
  </div>
  <div style="text-align: left; margin-left: 36pt; margin-bottom: 12pt; font-family: 'Times New Roman'; font-size: 10pt;">by the Participant shall terminate, and the Company may rescind any exercise of an Option or SAR and the vesting of any other Award
    and delivery of shares upon such exercise or vesting (including pursuant to dividends and Dividend Equivalents), as applicable on such terms as the Committee shall determine, including the right to require that in the event of any such rescission, (A)
    the Participant shall return to the Company the shares received upon the exercise of any Option or SAR and/or the vesting and payment of any other Award (including pursuant to dividends and Dividend Equivalents) or, (B) if the Participant no longer
    owns the shares, the Participant shall pay to the Company the amount of any gain realized or payment received as a result of any sale or other disposition of the shares&#160; (or, in the event the Participant transfers the shares by gift or otherwise
    without consideration, the Fair Market Value of the shares on the date of the breach of the restrictive covenant agreement (including a Participant&#8217;s Award Agreement containing restrictive covenants) or activity constituting Cause), net of the price
    originally paid by the Participant for the shares.&#160; Payment by the Participant shall be made in such manner and on such terms and conditions as may be required by the Committee.&#160; The Employer shall be entitled to set off against the amount of any such
    payment any amounts otherwise owed to the Participant by the Employer.</div>
  <div style="text-align: left; text-indent: 72pt; margin-bottom: 12pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(i)</font><font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 5.14pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Governing Law; Jurisdiction</u></font>.&#160; The validity, construction, interpretation and effect of the Plan and Award Agreements
      issued under the Plan shall be governed and construed by and determined in accordance with the laws of the State of Delaware, without giving effect to the conflict of laws provisions thereof.&#160; Any action arising out of, or relating to, any of the
      provisions of the Plan and Awards made hereunder shall be brought only in the United States District Court for the District of Delaware, or if such court does not have jurisdiction or will not accept jurisdiction, in any court of general jurisdiction
      in the State of Delaware, and the jurisdiction of such court in any such proceeding shall be exclusive.<a name="z_Hlk121318060"></a></font></div>
  <div><br>
  </div>
  <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman', Times, serif; font-size: 8pt; font-weight: normal; font-style: normal;">18</font></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>frpt-20241001.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 24.8.1.5246 Broadridge-->
<xs:schema targetNamespace="http://freshpet.com/20241001" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:frpt="http://freshpet.com/20241001" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:srt-types="http://fasb.org/srt-types/2024">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="frpt-20241001_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="frpt-20241001_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://freshpet.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2024" schemaLocation="https://xbrl.sec.gov/currency/2024/currency-2024.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2024" schemaLocation="https://xbrl.sec.gov/exch/2024/exch-2024.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2024" schemaLocation="https://xbrl.sec.gov/naics/2024/naics-2024.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2024" schemaLocation="https://xbrl.sec.gov/sic/2024/sic-2024.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2024" schemaLocation="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>frpt-20241001_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 24.8.1.5246 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract" xml:lang="en-US" id="dei_CoverAbstract">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract" xlink:title="label: CoverAbstract to dei_CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType" xml:lang="en-US" id="dei_DocumentType">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType" xlink:title="label: DocumentType to dei_DocumentType" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:label xlink:type="resource" xlink:label="dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_WrittenCommunications" xml:lang="en-US" id="dei_WrittenCommunications">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WrittenCommunications" xlink:to="dei_WrittenCommunications" xlink:title="label: WrittenCommunications to dei_WrittenCommunications" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:label xlink:type="resource" xlink:label="dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SolicitingMaterial" xml:lang="en-US" id="dei_SolicitingMaterial">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SolicitingMaterial" xlink:to="dei_SolicitingMaterial" xlink:title="label: SolicitingMaterial to dei_SolicitingMaterial" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementTenderOffer" xml:lang="en-US" id="dei_PreCommencementTenderOffer">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer" xlink:title="label: PreCommencementTenderOffer to dei_PreCommencementTenderOffer" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementIssuerTenderOffer" xml:lang="en-US" id="dei_PreCommencementIssuerTenderOffer">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:title="label: PreCommencementIssuerTenderOffer to dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag" xml:lang="en-US" id="dei_AmendmentFlag">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag" xlink:title="label: AmendmentFlag to dei_AmendmentFlag" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus" xml:lang="en-US" id="dei_DocumentFiscalYearFocus">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate" xml:lang="en-US" id="dei_DocumentPeriodEndDate">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName" xml:lang="en-US" id="dei_EntityRegistrantName">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey" xml:lang="en-US" id="dei_EntityCentralIndexKey">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber" xml:lang="en-US" id="dei_EntityFileNumber">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber" xlink:title="label: EntityFileNumber to dei_EntityFileNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1" xml:lang="en-US" id="dei_EntityAddressAddressLine1">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine2" xml:lang="en-US" id="dei_EntityAddressAddressLine2">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2" xlink:title="label: EntityAddressAddressLine2 to dei_EntityAddressAddressLine2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine3" xml:lang="en-US" id="dei_EntityAddressAddressLine3">Entity Address, Address Line Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3" xlink:title="label: EntityAddressAddressLine3 to dei_EntityAddressAddressLine3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown" xml:lang="en-US" id="dei_EntityAddressCityOrTown">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince" xml:lang="en-US" id="dei_EntityAddressStateOrProvince">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCountry" xml:lang="en-US" id="dei_EntityAddressCountry">Entity Address, Country</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCountry" xlink:to="dei_EntityAddressCountry" xlink:title="label: EntityAddressCountry to dei_EntityAddressCountry" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode" xml:lang="en-US" id="dei_EntityAddressPostalZipCode">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode" xml:lang="en-US" id="dei_CityAreaCode">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode" xlink:title="label: CityAreaCode to dei_CityAreaCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber" xml:lang="en-US" id="dei_LocalPhoneNumber">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle" xml:lang="en-US" id="dei_Security12bTitle">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle" xlink:title="label: Security12bTitle to dei_Security12bTitle" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:label xlink:type="resource" xlink:label="dei_NoTradingSymbolFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_NoTradingSymbolFlag" xml:lang="en-US" id="dei_NoTradingSymbolFlag">No Trading Symbol Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag" xlink:title="label: NoTradingSymbolFlag to dei_NoTradingSymbolFlag" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol" xml:lang="en-US" id="dei_TradingSymbol">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol" xlink:title="label: TradingSymbol to dei_TradingSymbol" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName" xml:lang="en-US" id="dei_SecurityExchangeName">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>frpt-20241001_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 24.8.1.5246 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://freshpet.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="frpt-20241001.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://freshpet.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentType" xlink:title="presentation: CoverAbstract to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="AmendmentFlag" xlink:title="presentation: CoverAbstract to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: CoverAbstract to DocumentPeriodEndDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalYearFocus" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalPeriodFocus" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityFileNumber" xlink:title="presentation: CoverAbstract to EntityFileNumber" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityRegistrantName" xlink:title="presentation: CoverAbstract to EntityRegistrantName" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCentralIndexKey" xlink:title="presentation: CoverAbstract to EntityCentralIndexKey" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: CoverAbstract to EntityIncorporationStateCountryCode" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: CoverAbstract to EntityTaxIdentificationNumber" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine1" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine2" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine2" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine3" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine3" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: CoverAbstract to EntityAddressCityOrTown" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: CoverAbstract to EntityAddressStateOrProvince" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCountry" xlink:title="presentation: CoverAbstract to EntityAddressCountry" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: CoverAbstract to EntityAddressPostalZipCode" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="CityAreaCode" xlink:title="presentation: CoverAbstract to CityAreaCode" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="LocalPhoneNumber" xlink:title="presentation: CoverAbstract to LocalPhoneNumber" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="Security12bTitle" xlink:title="presentation: CoverAbstract to Security12bTitle" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="TradingSymbol" xlink:title="presentation: CoverAbstract to TradingSymbol" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="NoTradingSymbolFlag" xlink:title="presentation: CoverAbstract to NoTradingSymbolFlag" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SecurityExchangeName" xlink:title="presentation: CoverAbstract to SecurityExchangeName" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: CoverAbstract to EntityEmergingGrowthCompany" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="WrittenCommunications" xlink:title="presentation: CoverAbstract to WrittenCommunications" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SolicitingMaterial" xlink:title="presentation: CoverAbstract to SolicitingMaterial" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementTenderOffer" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementIssuerTenderOffer" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.3</span><table class="report" border="0" cellspacing="2" id="idm45238371174000">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Oct. 01, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Oct.  01,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36729<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Freshpet, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001611647<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">20-1884894<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1545 US-206<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Bedminster<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NJ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">07921<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">201<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">520-4000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">FRPT<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>8
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M7>EYIK=WDWM)J'7N0;#W\!J-'<V/'[?\ 5!+ P04    " "(A419)!Z;HJT
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M2P$"% ,4    " "(A419!T%-8H$   "Q    $               @ $
M9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( (B%1%F 9];X[@   "L"   1
M              "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    (
M (B%1%F97)PC$ 8  )PG   3              "  <P!  !X;"]T:&5M92]T
M:&5M93$N>&UL4$L! A0#%     @ B(5$69\!SZPY!   ;Q   !@
M     ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    (
M (B%1%F?H!OPL0(  .(,   -              "  7P,  !X;"]S='EL97,N
M>&UL4$L! A0#%     @ B(5$69>*NQS     $P(   L              ( !
M6 \  %]R96QS+RYR96QS4$L! A0#%     @ B(5$61PX9>H_ 0  / (   \
M             ( !01   'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( (B%
M1%DD'INBK0   /@!   :              "  :T1  !X;"]?<F5L<R]W;W)K
M8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( (B%1%EED'F2&0$  ,\#   3
M          "  9(2  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D
*/@(  -P3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="a8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://freshpet.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="a8k.htm">a8k.htm</File>
    <File>frpt-20241001.xsd</File>
    <File>frpt-20241001_lab.xml</File>
    <File>frpt-20241001_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "a8k.htm": {
   "nsprefix": "frpt",
   "nsuri": "http://freshpet.com/20241001",
   "dts": {
    "inline": {
     "local": [
      "a8k.htm"
     ]
    },
    "schema": {
     "local": [
      "frpt-20241001.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/currency/2024/currency-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/exch/2024/exch-2024.xsd",
      "https://xbrl.sec.gov/naics/2024/naics-2024.xsd",
      "https://xbrl.sec.gov/sic/2024/sic-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "frpt-20241001_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "frpt-20241001_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 29,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 22
   },
   "report": {
    "R1": {
     "role": "http://freshpet.com/role/DocumentAndEntityInformation",
     "longName": "000100 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c20241001to20241001",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "a8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20241001to20241001",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "a8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://freshpet.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://freshpet.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://freshpet.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://freshpet.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://freshpet.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://freshpet.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://freshpet.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://freshpet.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://freshpet.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://freshpet.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://freshpet.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://freshpet.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://freshpet.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://freshpet.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://freshpet.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://freshpet.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://freshpet.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://freshpet.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://freshpet.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://freshpet.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://freshpet.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://freshpet.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://freshpet.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://freshpet.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://freshpet.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://freshpet.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://freshpet.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://freshpet.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0000929638-24-003440-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000929638-24-003440-xbrl.zip
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MFH9I+5J CR4Y'@RJ*J_'JK,TFCX3LK:Y=B%13*)T#&;QO[+83US?0;B39E"
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M*@78O&C$5%=!ERX:-"T%W]<C6KD^FHT3+B/:O$\W@FH(1+!O>=HW8>#SM1H
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MK%XN/"]6>IHBA*Q:I?JE_#3_G?^2_W[8M2-WAO^.TTFP]_]02P,$%     @
MB(5$66A#'81_8P  <EP"  \   !E>&AI8FET,3 M,2YH=&WMO6ES&T>6-OK]
M1MS_4-<S_;YD!.0&N-/R= 2XB3ME:G&[OTP4@ 108J$*K@4@^.MOGB6W6D!0
M)"W(PDQ$6R2!JEQ.GCS+<Y[SZS ;A?_Z?_\?S_MU*/P>_DO^.PNR4/SKUW_2
M?_F7_]^;-]YET!51*GI>%O_B7<7)P(^\2S$-4H\^A/]W%'?SD8@RKYL(/Y,?
MSM,@&G@'2>SWDJ W$-[[VYM^$ IO8^OGO9];/V]O;.U8WS^,Q[,D& PSK[6_
MO^V]\3::&UOVU]^\H2'_D\?\:R?NS;S.H!N'<?(_/_U7'__O)R_-9J'XGY_Z
M<92]Z?NC()S]XOW?C\%(I-ZUF'JW\<B/_F_#P]\TO%0D0?^MAY].@P?QB]=J
MCK.W7B;NLS=^& RB7[Q0].5O\#V_>/_5Q/][^Q.-1JX/S^N]/Q#7^:@CDEN1
MBNP?\M__:/WC'_]0X^X%$S4V^^$X9_FT7V$(SN"G O[TB]>)PY[\P/'],.@$
M<GF:/[=^_2=\XE^_=A)>$_EP_98G_%K]IF9L<MLSD;SU1GXR"*(WG3C+XI%<
MH8UQ]8CM!9R__OSWPA1_];W('\FG/?SO:7C7:NWN-/>;>TWYAW_ZQ3]NM#9;
M>\WM_>H_[FUM[#:;6_3'D]OC#Z?OCS\VO+/KPY^?->R?]"KBZ:!M0$D]_NW3
MV<<_X W'UQ_//A][[R_;UR__KKD[7[6')+SXFR#JR0W]Q=O<@;=7;>IBNV;-
MX46D +_\BQ=D<LA=^<@/HIL%<>2U?OX__]7::;[UW/\<]_OP@8F(1)IZ?M3S
MWN?).$X%K\W/+[<H.U^W)GJ$GI]Z<=_+AL*,VCN2ZK&!O[.D=O_N=O/WC\G&
MSL[6X?%O%V'KZ/CTTV]'.SO7T;]G?VZ<'9\>?PDW=RJE'<]):Y//R4DBTN%8
M9 V2G+.H^S/ITN,_\R";P2_DA&$@[T.IR-?D$$>^5*1RL%)_]Z3F[E>/Z^#L
M\R/C2N*1E\GUD1<%_I=F^7_^:V]CH_FVXJ%;6UO'E]WWPSN>ULLKE/Q?,,E?
M_YFK@X.#:;U=I\615]A0)*(S\T2:^9TP2(>B]^WEYZ-<M3')M!(?W"LY7+FR
MXR2>!+V"]%R=OMO^XW.VM;.S<WS]^?3AX>%H*Z1E%:-Q&,^$0%&L%)W61JWH
M-#S?.Q*A/_43(:] .:;$Q\.YEL4#(4>6>-,@&\K#FWIIWNW*(QDGJ;OQK[&M
MA_%H[$>SBIUMH$J \7S(.VG0"_PD@)N^*Y+,#R(YB2C-P\R/,E(>?F\2P)B]
MZ5"NK4CZ<3("LV BK9Y4OCZAQ8 )\4N].*EX/CPKBJ,W[K:<G3ZV+=Y(@-&@
M%<5![">]!JTJ_!R/Y9IG>01G5^Y^(KH"#F_=[I]<?KH9C_A #A*<IGRRH,,/
M^]A+/;D,\&B<JBL4[K.N_GT5]9/=S9W-3G@\FP3!Q7'['3TZT&HDS>+NG1PF
MB(5<A]J'7?<^/&RT)]$TD3+2BT];LS"\/CTZI^?)I?LSE\>K'T@-5'@D_>B/
MQW+R 8D?FDWSWG;SI;L]'EU^>)@\T OX(;@ <[[W_@Z^U^_-MNVOP?+S'M=]
M\]WIO_^8W4WNANT\N3UL;B<WW7UEGL1X4/!1;SH^F-(T#G7!'?ICO/T>P,@6
MR2B5UK/\)V\3GGT2K\S#1TG;6W@]T0\B^2G08/*3Z= /0V_HRQV!+XV$'X$!
M[J>I5%EHO,/O1_*A)-!\R]((-I9#Z5E:3D1#7XH8SD5JO+Y<GTX0H@S+E9CX
M8:YUHSJ64ISQYXZT#.3GX<^HEF#9AU)SP"$#51^!II=+8W]7OC&6-S0?=B%G
M''2DKS+VDRSH!F,\1G@DG4V,>O^4[^SZZ9!_HT\%GK$XD>^$1_M9EOC=K"%/
M+^H@F$(B0 1 :4KM&<DU#WI2_DDGI5DBHH$<'PG *,_@:,BYPY3 )I?7E9R+
MR*9"?J3R$=;D0#.V=M^Z*[%<&PZ30ML#-=PX]'GGWR>!7&#XE#HJUW(U>[T
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M=SDT"D \9"S"Q?KYA6.BSCE [\Z-B@0IT4G3CIO]JD*X6+T3G!+]NF*:.JG
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MRMF$$DP582*541TO=.P=>NB<#LW\\ NA4R)MQ=_TE.<H/\GJ*:TB9%Y'VFK
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M 1E=NLB!BJI)*'*#,!"Y!A%4+$>BWU3_"?M PI&&)$V!^5H:9GT1< +!3%Y
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MV?N?Y9"8UY#V6ZZ%V,=127;]%U!+ P04    " "(A4193X&"^7L(   P5@
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MPQA:(USW[X2YVDUC?;,](R0= MY45XAZ.P,0^DH/D/\F7(*?TJNM'^OY7):
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MVQ#+ZXELW:?Q>6Q5.BW_('*'1N,?9C\B(=CS$]FFBA![%F4$5=7F6>RF@@9
M\(+<THB_K^[F:3DC*?#(G4513PM4>+!HB>B#(^S61"2DGEX05+>BJKD##^;9
MZD,:$RJ3"0@%G"Y%#L"G%%1A!;35$U)L'C2"47PX5!V:")1U4QF\_3('9YY8
M$B9S)DD$8?:2!;S\?EC']ZP &'A0PR91+L.RI(5+,12SC<NQXK?IDBS)IZ(5
MB>8./*AA+1)I3BI\==Y5JE=HJ-:[.3AGG_A;6^NFI'K+Z?1_4$L#!!0    (
M (B%1%E5+,<6VP4  /$^   5    9G)P="TR,#(T,3 P,5]P<F4N>&ULU5M=
M;^(X%'U?:?]#EGV&%.ATAZK,B&7:$1JF1875?KRL3&+ VB1&3BCP[]<.=DL<
MVPG]&-V^M)![?'VNSXE#+N'J\RZ.O ?,4D*3?J/=.FMX. EH2))EO[%)FR@-
M"&E\_O3S3U>_-)M?<8(9RG#HS??>[XRBD)%PB;W)_=V"1-CKG+<^MMJM#YWS
MBZ-PLRF&1R3Y[U+\F:,4>WS:)+W<I:3?6&79^M+WM]MM:]MM4;;T.V=G;?^O
M[^-IL,(Q:I(DS5 2X(;'\9=I?G!, Y3EG(^&[^8L4@FZ_N-<5H1XUU2PICC4
M;'>:W79KEX8-25&$:TRBX+L27M;4[O5Z?AY]A/)$Q)'ZL6R^>IYW6#]&(WR/
M%Y[X_\?]R#JZYPN$G^!LC.8XXE/FP[/]&O<;*8G7$5;'5@POS'DBQA[3B-7I
MB=5I7XC5^?4IL_\2>DMAIAG-4/0Z//-\9:ZE:5Y.^O:UEM9%^?8U5YF?Y/@'
MK/+1-"\G/<&,T/ Z"=^>N#[5:Y&?9HC] *N4)WMY 6_/^@2J"X;3U1IGK8#&
MA]1?:+")<9(-$BY;1K+]*%E0%N?7A6K6"[86NUKGO,VO-CDG=[YCCFO.A0/S
MR)@?*$R&=QE.0ARJZ037YU:1SZEFC6A0F"@2UT#*RF*D?*)<B10'K25]\$-,
M?%&J>)'7G-?+W_P[I/SB/YBG&4-!IC)%0I5^PQCC#$4Y6LQ_<Z)JF68\H\;3
M%)(TBZ$BRV,1!ZS(&+% 9>(O"PJ6+]02X:\1X_F:P8I$C^(O&(UM*TF=U(_I
M77J%#%Y&O>)(RD+,^HTS\?F-#UQ@QN3)Y>"=DXZ.S\"W%'# V8:"\4V$EIJ"
MQIA<!RT&3T,7^0H1M:%2Q39@%97M'J^67_@V;CD?C1CMQ-0P\-2M4TS-4U5+
M(=7NO .U;T@:H.AOC-@-/Y):]+:@-,5+*+B:NPNJJ7HIB=2]^VYT/_BV6GD#
MSJA] 0==?7M1)^E?2",=< [8 8>/HC<DPK>;>(Z9)KPM+)>F'(8G<T4)%>J6
M1TM1/X 7]1XOB2@DR6Y1K%^[79""N#H$JL#.4FJ)K&>00E^ %WK(2V,H&O&;
MT=TWO#<J;<$4I"YAH&KM+J:6V*444NW?P*L]2@+*UI3E]4UYF7A(-[R8_9"&
MYK.\UHB"$RI&0/7%*876<DE%0NF9C^ ],T.[4<BK)0MR^#K%<;&OP!9\8L5"
M=4B]XFIYPYI*NJ('WA6#,.2%IO+?F"2X;72$ U=P@Q$'U0G51=5R@3&-ZN]
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M.S]$Q!_Q,^U/_P-02P$"% ,4    " "(A419,PS1T;XA  #\W0  !P
M        @ $     83AK+FAT;5!+ 0(4 Q0    ( (B%1%EH0QV$?V,  ')<
M @ /              "  >,A  !E>&AI8FET,3 M,2YH=&U02P$"% ,4
M" "(A419  LX8T0#   Y#P  $0              @ &/A0  9G)P="TR,#(T
M,3 P,2YX<V102P$"% ,4    " "(A4193X&"^7L(   P5@  %0
M    @ $"B0  9G)P="TR,#(T,3 P,5]L86(N>&UL4$L! A0#%     @ B(5$
M654LQQ;;!0  \3X  !4              ( !L)$  &9R<'0M,C R-#$P,#%?
=<')E+GAM;%!+!08     !0 % #<!  "^EP     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>a8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="frpt-20241001.xsd" xlink:type="simple"/>
    <context id="c20241001to20241001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001611647</identifier>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-10-01</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="c20241001to20241001"
      id="Fact_8719ba46677140f8a553862cf9201145">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="c20241001to20241001"
      id="Fact_4a22d9d8b0c64e2dbcd69ed8b81b38c4">0001611647</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="c20241001to20241001"
      id="Fact_94b11ffce3ed466b9ba38a12c9ab0409">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="c20241001to20241001"
      id="Fact_e6e52aba8de04d50857d4680e72c04b2">2024-10-01</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="c20241001to20241001"
      id="Fact_a9b5e8a22142426cab4c38dce8b9c239">Freshpet, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20241001to20241001"
      id="Fact_d73bb40c90124970ba2c53fcc32fd5eb">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="c20241001to20241001"
      id="Fact_f3b4c45146404374ac91e2beff8de354">001-36729</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20241001to20241001"
      id="Fact_318477988b4e46b3a4882c5af0d7e8ff">20-1884894</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20241001to20241001"
      id="Fact_005ee561ce004326be248d2ca1d4aeac">1545 US-206</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="c20241001to20241001"
      id="Fact_64c94359c0ac42b8b7b81a344a353cf8">Bedminster</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="c20241001to20241001"
      id="Fact_7622f32dff2742edb5adda4c4f47802f">NJ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="c20241001to20241001"
      id="Fact_0df34df1e82c42d98870256de5317e84">07921</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="c20241001to20241001"
      id="Fact_3e20be1178ce4249a53e409e9fca219c">201</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20241001to20241001"
      id="Fact_98689e1658eb4392a424a125add0bb88">520-4000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="c20241001to20241001"
      id="Fact_c48f18e9c5ff4fef980264a31beeaab1">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="c20241001to20241001"
      id="Fact_7cccb5f9da3d4c3399bf30d798d936e6">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="c20241001to20241001"
      id="Fact_1fc52929777e4b51a625aaaf4dd70c90">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="c20241001to20241001"
      id="Fact_877a69b0d679407b9ababaa44d5ab86e">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="c20241001to20241001"
      id="Fact_88557b421be9437c83ad47e52930083b">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20241001to20241001"
      id="Fact_b536462fd8d646a7ba7ebb239654e0dc">FRPT</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="c20241001to20241001"
      id="Fact_237bd22b09de49d9bd61f08ead026971">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20241001to20241001"
      id="Fact_ba935a196fcf4006bdc1157b511f0d29">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
